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ABSTRACT
Differences in Smoking Behaviors and Readiness to Change for Patients with COPD and
Differing Categories of Depression
Jessica Floyd
Background: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
in the world. Depression is a common comorbidity of COPD and affects patient outcomes and
smoking cessation. The purpose of this study was to explore and describe factors influencing
smoking behaviors and readiness to change in patients with comorbid COPD and depression.
Aims: The research question that guided this study was, “What are the relationships among
smoking, COPD, and depression?” The following aims stemmed from the research question: to
describe the characteristics of a convenience sample of people living with COPD and differing
categories of depression who sought care in West Virginia; to describe the differences between
people with COPD and differing categories of depression (minimal, mild, moderate, moderately
severe, severe, or no depression) related to smoking behaviors and readiness to change; to
explore the relationships among COPD, depression, smoking behaviors, and readiness to change;
and to analyze the relationships among COPD, depression, smoking behaviors, and readiness to
change.
Methods: A descriptive cross-sectional design was used. A convenience sample of 222 COPD
patients participated in the study. COPD was self-reported. Depression was assessed through the
PHQ-9. Smoking behaviors were assessed through The Cigarette Dependence Scale. Readiness
to change was assessed through The Smoking Stage of Change Questionnaire, The Smoking
Decisional Balance Questionnaire, and The Processes of Change Questionnaire. Electronic and
paper questionnaires were collected using various recruitment strategies. Data was stored in
RedCap and analyzed using SPSS version 26. Descriptive analyses were conducted and
ANOVA, t-test, chi-square, Pearson correlation, linear regression, and multiple linear regression
were used to analyze the relationships among smoking, COPD, and depression.
Results: Most participants were older white females who were of lower socioeconomic status
that completed high school or some college. Diabetes mellitus and congestive heart failure were
the most prevalent comorbid conditions. Only 18 participants were classified as having no
depression. The majority of participants were in the maintenance or contemplation stage.
Participants who smoked had high nicotine dependence and wanted to quit smoking. Overall,
participants saw more cons to smoking and were engaged in the processes of change.
Conclusions: There is a need to assess COPD patients for depression and to assess COPD
patients’ smoking behaviors and readiness to change. Depression does affect patients’ smoking
behaviors and readiness to change. Adequate treatment of depression could promote an
individual to move through the stages of change from chronic contemplation to action, thus
improving smoking cessation efforts for individuals with COPD. Understanding patients’
smoking behaviors and readiness to change can aid in developing personalized interventions to
achieve smoking cessation and long-term outcomes.

iii

Table of Contents
Chapter One: Introduction .......................................................................................................... 1
Statement of the Problem ............................................................................................................ 1
Background of the Problem......................................................................................................... 2
Purpose Statement ....................................................................................................................... 4
Research Question ....................................................................................................................... 5
Theoretical Framework ............................................................................................................... 5
Significance to the Discipline of Nursing ................................................................................... 8
Chapter Two: Review of the Literature.................................................................................... 11
Smoking .................................................................................................................................... 11
Smoking Behaviors ................................................................................................................... 13
Smoking Cessation .................................................................................................................... 15
Readiness to Change ................................................................................................................. 19
Theoretical Framework ............................................................................................................. 22
Chapter Three: Methods ............................................................................................................ 26
Research Design ........................................................................................................................ 26
Human Subject Protection ......................................................................................................... 27
Sample ....................................................................................................................................... 29
Study Variables and Instruments............................................................................................... 30
Procedures and Data Collection ................................................................................................ 34
Plan for Data Analysis............................................................................................................... 35
Feasibility of Proposed Research .............................................................................................. 37
Chapter Four: Results ................................................................................................................ 39
Aim 1 ......................................................................................................................................... 39
Aim 2 ......................................................................................................................................... 63
Aim 3 ......................................................................................................................................... 64
Aim 4 ......................................................................................................................................... 66
Chapter Five: Findings ............................................................................................................... 70
Aim 1 ......................................................................................................................................... 70

iv

Aim 2 ......................................................................................................................................... 75
Aim 3 ......................................................................................................................................... 77
Aim 4 ......................................................................................................................................... 78
Limitations ................................................................................................................................ 80
Conclusion ................................................................................................................................. 82
References .................................................................................................................................... 83

1
Chapter One: Introduction
Tobacco is a worldwide epidemic. Although differing forms of tobacco exist, 90% of
tobacco used is through cigarette smoking (Prochaska, Das, & Young-Wolff, 2017). Smoking is
the leading source of death and preventable diseases (Centers for Disease Control and
Prevention, 2019a). Globally, 7 million people die each year from tobacco (World Health
Organization, 2019). In the United States, the burden of tobacco is vast. Approximately 34
million adults in America smoke, and tobacco causes one out of every five deaths in the country
(Centers for Disease Control and Prevention, 2019a). Treatment for smoking-related diseases
costs the United States approximately $170 billion in medical expenses annually (Centers for
Disease Control and Prevention, 2019b). This chapter introduces the difficulty of achieving
smoking cessation, the physical and psychological consequences of smoking, and how
individuals’ smoking behaviors and their readiness to change influences smoking cessation.
Statement of the Problem
Smoking cessation is difficult, and nicotine withdrawal impacts physical and
psychological health. The difficulty of quitting nicotine addiction is comparable to heroin
(Smoke Free, 2019a). Nicotine, the addictive component in cigarettes, controls the brain. While
smoking, the brain receives regular doses of nicotine, and over time, the brain develops extra
nicotine receptors (Smoke Free, 2019a). When the brain receives reduced levels of nicotine, an
individual begins to experience nicotine withdrawal (Smoke Free, 2019a). Nicotine withdrawal
can cause difficulty sleeping and an increased appetite (Smoke Free, 2019b). It can also cause
cravings, irritability, sadness, and poor concentration (Smoke Free, 2019b). Although
experiencing these symptoms can be difficult, continuing to smoke has a significant negative
consequence on an individual’s physical and psychological health (Smoke Free, 2019a).
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Background of the Problem
Physical Impact of Smoking
Smoking negatively affects almost every organ in the human body (Centers for Disease
Control and Prevention, 2018). Currently, 16 million Americans suffer from smoking-related
diseases (Centers for Disease Control and Prevention, 2019a). Smoking leads to many different
types of cancers, including, lung, esophageal, liver, pancreatic, and stomach (Centers for Disease
Control and Prevention, 2018). By increasing the blood viscosity and causing vasoconstriction of
the blood vessels, smoking causes hypertension and thrombus formation. This formation leads to
cardiovascular diseases, such as coronary heart disease and cerebral vascular accidents. By
damaging the alveoli in the lungs, smoking also leads to or worsens lung diseases, such as
chronic obstructive pulmonary disease (COPD), asthma, chronic bronchitis, and emphysema
(Centers for Disease Control and Prevention, 2018). In the United States, 11 million people have
COPD, and millions more may be undiagnosed (American Lung Association, 2017). Despite the
physical consequences of smoking, it is often the psychological impact of smoking that makes it
difficult to achieve cessation.
Psychological Impact of Smoking
Nicotine causes physiological changes in the brain (Mental Health Foundation, 2019).
The prevalence of smoking is highest in individuals diagnosed with bipolar disorder, substance
use disorders, schizophrenia, depression, and post-traumatic stress disorders. In the
schizophrenic population, smoking is known to cause poor problem-solving skills and poor
verbal memory. In the bipolar population, smoking is associated with more severe and frequent
psychiatric symptoms (El-Mallakh, McPeak, Khara, & Okoli, 2016). In the United States,
approximately 17.3 million adults report having a depressive episode (National Institute of
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Mental Health, 2019). Being a smoker doubles an individual’s risk for developing depression,
and in heavy smokers, that risk quadruples (Prochaska et al., 2017).
Smoking Cessation
More than half of adult smokers desire to achieve smoking cessation; however,
physiological and psychological factors exist that make this process very challenging (Centers
for Disease Control and Prevention, 2017). Smoking was once viewed as a bad habit, but it is
now seen as tobacco use disorder, a chronic and relapsing disease (Woody, DeCristofaro, &
Carlton, 2008). Changing this health behavior is a complex process, and the majority of smokers
are not ready to implement change (Prochaska & Velicer, 1997). If an individual is not ready to
implement change, most cessation attempts will fail, and relapse will occur. Individuals’
readiness to change should be assessed prior to implementing smoking cessation interventions
for optimal outcomes (Woody et al., 2008).
Smoking Cessation and Psychological and Behavioral Health
In addition to being ready to change, individuals with a psychological and behavioral
health diagnosis have additional challenges when trying to achieve smoking cessation. In the
United States, these individuals consume nearly half of the cigarettes sold (Prochaska et al.,
2017). They have greater nicotine dependence, resulting in increased withdrawal symptoms and
fewer quit attempts. On average, smokers with psychological and behavioral health diagnoses die
25 years earlier (Prochaska et al., 2017). With the consistent prevalence of smoking in this
population, it is apparent that smoking cessation interventions for the general population are not
effective for individuals with a psychological and behavioral health diagnosis (Prochaska et al.,
2017).

4
Smoking in West Virginia
The impact of smoking on COPD and depression is evident in West Virginia. In 2017,
West Virginia led the United States with the highest percentage of smoking adults at 26%
(United Health Foundation, 2019). In 2015, West Virginia had the highest prevalence of COPD
in the United States at 12.1% (American Lung Association, 2017). The prevalence of depression
among Medicare patients in West Virginia is 16.7%, which differs from the United States as a
whole, in which the prevalence of depression among Medicare patients is 15.4% (Appalachian
Regional Commission, 2017). There is a need to explore how depression as a comorbidity affects
smoking behaviors and readiness to change in the COPD population of West Virginia.
Relevance of the Problem
The 2025 Healthy People goal is to reduce tobacco use in the United States to 12%
(Prochaska et al., 2017). To improve smoking cessation outcomes, interventions are needed to
address smoking behaviors concurrently with psychological and behavioral health symptoms (ElMallakh et al., 2016). Given the prevalence of COPD and depression for the state of West
Virginia, there is a critical need to understand factors impacting cessation in this population.
Smoking cessation can alter the physical and psychological effects of smoking; however,
individuals need to be ready to implement change.
Purpose Statement
The purpose of this study was to explore and describe factors influencing smoking
behaviors and readiness to change in patients with comorbid COPD and depression. Factors that
influence smoking behaviors and readiness to change may contribute as facilitators and/or
barriers to achieving smoking cessation.
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Research Question
The research question guiding this study was, “What are the relationships among
smoking, COPD, and depression?” The following aims stemmed from the research question: to
describe the characteristics of a convenience sample of people living with COPD and differing
categories of depression who sought care in West Virginia; to describe the differences between
people with COPD and differing categories of depression (minimal, mild, moderate, moderately
severe, severe, or no depression) related to smoking behaviors and readiness to change; to
explore the relationships among COPD, depression, smoking behaviors, and readiness to change;
and to analyze the relationships among COPD, depression, smoking behaviors, and readiness to
change.
Theoretical Framework
The Transtheoretical Model was the theoretical framework that guided this study. The
Transtheoretical Model calls for a paradigm shift and assumes that changing a health behavior
takes time and requires progression through a series of stages. This comprehensive model
integrates multiple theories on the belief that a single theory cannot explain the intricacies of
behavior change. It challenges the belief that action-oriented programs are for everyone—also
known as the action paradigm—and calls for a stage paradigm. A stage paradigm assumes that
the majority of individuals are not ready to take action. Instead, the Transtheoretical Model
assesses the essence of the behavior, identifies the stage of change individuals are in, and then
selects stage specific interventions that aid in promoting change. This approach is designed to
personalize interventions and enhance personal self-control. The Transtheoretical Model includes
five stages of change, ten processes of change, decisional balance, self-efficacy, and temptation
(Prochaska & Velicer, 1997).
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Five Stages of Change
The core constructs of the Transtheoretical Model include the following five stages of
change: precontemplation, contemplation, preparation, action, and maintenance.
Precontemplation refers to individuals who are not ready to change. These individuals do not
recognize the consequences of their health behaviors and have no intention of acting within the
next six months. Contemplation refers to individuals who are planning to change within the next
six months. Individuals in this stage contemplate the positive and negative aspects of changing
their health behavior. Often times, uncertainty causes individuals to dwell in the contemplation
stage. This is referred to as chronic contemplation or behavioral procrastination. Preparation
refers to individuals who have a plan to act within the next month. Action refers to individuals
who have altered their behavior within the past six months. Maintenance refers to individuals
who are continuing with their change behavior and are trying not to regress to a previous stage.
The maintenance stage can last from six months to five years (Prochaska & Velicer, 1997).
Ten Processes of Change
To progress from one stage to another, individuals use the following ten processes of
change: consciousness raising, dramatic relief, self-reevaluation, environmental reevaluation,
self-liberation, social liberation, counterconditioning, stimulus control, contingency/
reinforcement management, and helping relationships (Prochaska & Velicer, 1997).
Consciousness raising refers to when individuals recognize the health behavior and acknowledge
the consequences. Dramatic relief refers to when individuals have experiences that produce
heightened emotions. Grieving, listening to a testimony, or role playing are all examples of
dramatic relief. Self-reevaluation refers to when individuals reevaluate their self-image in the
presence of and without the health behavior. Environmental reevaluation refers to when
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individuals assess how their health behavior affects their social environment. Self-liberation
refers to when individuals believe they can change and can also commit and recommit to change.
Social liberation refers to when individuals experience more social opportunities.
Counterconditiong refers to when individuals learn that a new health behavior can replace a poor
health behavior. Stimulus control refers to when individuals remove unhealthy behavior cues and
replace them with prompts for healthy behavior. Contingency/reinforcement management refers
to when individuals face consequences or receive rewards for certain decisions. Helping
relationships refer to when individuals experience social support for their new health behavior
(Prochaska & Velicer, 1997).
Decisional Balance, Self-Efficacy, and Temptation
The Transtheoretical Model also includes the constructs of decisional balance, selfefficacy, and temptation. Decisional balance refers to the pros and cons individuals consider
when they are making a change. Self-efficacy refers to individuals’ confidence related to their
changed behavior and their will not to regress to previous stages. Temptation refers to the urges
individuals experience when they are placed in challenging situations (Prochaska & Velicer,
1997). For this study, decisional balance was measured. Self-efficacy and temptation were not
measured in this research study.
The Transtheoretical Model provided a framework for exploring factors influencing
smoking behaviors and readiness to change for individuals with comorbid COPD and depression
(Prochaska & Velicer, 1997). This model provided a lens to understand how depression as a
comorbidity impacts smoking behavior and readiness to change for patients with COPD. The
core constructs of the Transtheoretical Model guided inquiry on this research problem and
provided a framework for focusing on caring in the human health experience.
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Significance to the Discipline of Nursing
This study on smoking behaviors and readiness to change contributes to the body of
nursing knowledge. The perspective of the discipline of nursing is caring in the human health
experience (Newman, Sime, & Corcoran-Perry, 1991). To stimulate inquiry for the discipline,
caring in the human health experience provides a philosophical lens for knowledge development.
New knowledge must address caring and human health experience to be considered nursing
knowledge (Newman et al., 1991). Smoking behaviors, readiness to change, stages of change,
and processes of change are all integral parts of the human health experience. To generate new
nursing knowledge, one must care for individuals, understand their human health experience, and
examine how depression as a comorbidity impacts their experience. This study was grounded in
the philosophical perspective of caring in the human health experience to ensure sound
knowledge was developed (Polifroni & Welch, 1999).
Implications for Nursing Practice
Newly generated knowledge about the human health experience of smoking behaviors
and readiness to change also is expected to be foundational in developing new implications for
nursing practice. Individuals with COPD and depression are a vulnerable population, and it is
imperative that their complex health care needs are addressed. Findings from this study will help
identify factors that may aid in the management of individuals with COPD and depression. This
study is innovative in its approach, because people with comorbid COPD and depression who
sought care in West Virginia, are an understudied population of disparity.
Implications for Health Policy
It is expected that the findings from this study will have policy implications related to
adequate smoking cessation tools in West Virginia. The Centers for Disease Control and
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Prevention (CDC) recommends that West Virginia allocate $27.4 million for tobacco prevention.
However, for the 2017 fiscal year, the state allocated $3 million, and for the 2018 fiscal year, the
state did not fund tobacco prevention (American Cancer Society Cancer Action Network, 2017).
Established in 2000, the West Virginia Tobacco Quitline is a free service available to West
Virginia residents to aid in tobacco cessation. The Quitline provides free educational materials,
four free phone calls from Quitline coaches, and eight weeks of free nicotine replacement
therapy. The Quitline coaches are trained in motivational interviewing and behavioral
modification (Division of Tobacco Prevention, 2018). Currently, the Quitline is the busiest
Quitline per capita in the United States with more than 70,000 participants enrolled since 2000;
however, the Quitline has a quit rate of only 33.4% (Division of Tobacco Prevention, 2018). It is
possible that a policy change designed to target interventions for individuals with comorbid
COPD and depression would result in increased quit rates. The findings from this study are
aimed to identify how individuals with COPD and depression progress through the stages of
change, and this would provide new targets for smoking cessation treatment. Finally, results
from this study provide understanding of the population’s smoking cessation behaviors, and this
information could provide justification for future funding.
Conclusion
Smoking is the world’s greatest public health threat (Organization, 2019). To reach the
2025 Healthy People goal and reduce tobacco use in the United States to 12%, studies are needed
that include people who are current tobacco users and diagnosed with comorbid COPD and
depression (Prochaska et al., 2017). Exploring factors that influence smoking behaviors and
readiness to change in this population will contribute knowledge that can aid in reaching this
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goal. An integrated literature review is presented in Chapter 2. The variables that are considered
in the literature are COPD, depression, smoking behaviors, and readiness to change.
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Chapter Two: Review of the Literature
The purpose of this study was to explore and describe factors influencing smoking
behaviors and readiness to change in patients with comorbid COPD and depression. A broad
integrated literature review was conducted on the variables: COPD, depression, smoking
behaviors, and readiness to change. The findings from the literature are synthesized in this
chapter.
Smoking
The tobacco epidemic poses physical and psychological health consequences around the
world. Nicotine, a natural pesticide on tobacco leaves, is the leading addictive property in
cigarettes (Prochaska et al., 2017). This addictive property causes the majority of cigarette
smokers to develop nicotine dependence (Goodwin et al., 2012). Dependence on nicotine is
considered a mental disorder, according to the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) (Goodwin et al., 2012).
Physical Impact of Smoking
Smoking increases individuals’ vulnerability to medical illnesses (El-Mallakh et al.,
2016). It is a modifiable risk factor for many diseases, such as cancer, cardiovascular diseases,
and respiratory diseases, and it negatively affects overall health (Centers for Disease Control and
Prevention, 2018). In a study looking at the relationship between smoking and physical and
psychological health, findings showed that smokers report worse physical health than
nonsmokers. Physical health was measured by physical function, role function, body pain, and
general health. Using the Short Form Health Survey (SF-36), a higher score indicated a better
physical health status. For smokers, the scores in the four physical health categories were 1113% lower than nonsmokers (Woolf et al., 1999). Smoking can also exacerbate other conditions.

12
In individuals with impaired mobility, smoking can cause a decrease in strength and endurance
(Lee, Park, Kim, & Shin, 2014). The effects of smoking can also go unnoticed. It is estimated
that 31-45% of “healthy” smokers do, in fact, have COPD (Toljamo, Kaukonen, Nieminen, &
Kinnula, 2010).
Psychological Impact of Smoking
An association exists between smoking behaviors and a psychological and behavioral
health diagnosis (Shi, 2014). Smoking is most prevalent in patients with a psychological and
behavioral health diagnosis. Tobacco use is also reported as a risk factor for developing a
psychological and behavioral health diagnosis (Michal et al., 2013). There is a dose-response
relationship between smoking behaviors and anxiety and mood disorders (Goodwin et al., 2012).
Smoking has also been identified as a predictor of suicide attempts and other substance use
(Prochaska et al., 2017). Furthermore, smoking behavior impacts disease management and
outcomes. Nicotine can interact with the therapeutic levels of certain psychiatric medications
(Prochaska et al., 2017) and has been identified as a contributing factor to diminishing promotion
activities in those with a psychological and behavioral diagnosis (El-Mallakh et al., 2016). In the
United States, more than 40% of tobacco-related deaths reported are individuals with a
psychological and behavioral health diagnosis (King, Reboussin, Spangler, Cornacchione Ross,
& Sutfin, 2018).
Biobehavioral Impact of Smoking
A relationship exists between the physical and psychological consequences of smoking.
This relationship is bidirectional, in which each component can influence the other. Compared to
those who are physically ill, patients who suffer from depression and a chronic illness are less
likely to be social and physically active (Yohannes, Hann, & Sibbald, 2011). These patients are
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also more likely to be non-adherent with medical care. These health behaviors affect health
outcomes and lead to premature deaths (Yohannes et al., 2011). Higher depression levels also
correlate with physical symptoms, such as shortness of breath, fatigue, and frequency of COPD
symptoms (Bratek et al., 2015). Likewise, with an increased severity of COPD, an increased
prevalence of depression is seen in those who smoke (Bratek et al., 2015).
Smoking Behaviors
Smoking is a behavior that is characterized by the differing actions associated with
smoking cigarettes. Common measurable smoking behaviors include smoking status, frequency
of use, and nicotine dependence levels.
Smoking Behaviors and Psychological and Behavioral Health
While the prevalence of smoking has decreased among the general population, it has
persisted among the psychological and behavioral health population (Japuntich et al., 2018). For
eight years between 2001 and 2010, the United States prevalence rate of smoking remained
unchanged among those with poor psychological and behavioral health (Steinberg, Williams, &
Li, 2015). During these same years, the prevalence rate of smoking among those with better
psychological and behavioral health decreased significantly (Steinberg et al., 2015).
Approximately 40-60% of individuals with depression also smoke tobacco, 19.2-56% of
individuals with anxiety smoke, and 43-80% of individuals who abuse alcohol smoke (Michal et
al., 2013). Individuals with psychological and behavioral health diagnoses reported being
habitually heavy smokers. These individuals smoke more cigarettes daily than those without a
psychological and behavioral health diagnosis and report having high levels of nicotine
dependence (Steinberg et al., 2015). This same population reports a strong desire to achieve
cessation, yet they perceive abstinence as being very difficult (Richardson, McNeill, & Brose,
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2019). Consequently, they are less likely to achieve cessation than the general population (Burns,
Strawbridge, Clancy, & Doyle, 2017).
The increased prevalence of smoking in this population has been related to an increase in
the rates of smoking initiation and a lack of smoking cessation. This rationale is supported in the
literature by the low number of never smokers and/or ex-smokers in the psychological and
behavioral health population (Richardson et al., 2019). There is a gap in the literature related to
smoking behaviors, barriers to smoking cessation, and specific psychological and behavioral
health diagnoses (Richardson et al., 2019).
Smoking Behaviors and COPD
Patients with COPD are known to have particular smoking behaviors, including a higher
number of cigarettes smoked than smokers without a comorbidity. Patients with COPD also have
high levels of nicotine dependence. While studying smoking characteristics of those with severe
COPD who were seeking cessation treatment, researchers reported that patients with COPD
smoked an average of 29.72 cigarettes daily. Participants also had a Fagerstrom Test for Nicotine
Dependence score of 7.49, indicating high dependence (Jiménez Ruiz et al., 2012). This study
found that additional smoking characteristics of the COPD population included a higher
prevalence in males (65.6%), advanced age (58.31), and advanced history of smoking (40.58
years). Additionally, it found that 84% of participants smoked their first cigarette within the first
30 minutes of their day (Jiménez Ruiz et al., 2012). These smoking behaviors in persons with
COPD are contributing factors that makes achieving cessation a challenge (Jiménez Ruiz et al.,
2012).
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Smoking Behaviors in West Virginia
Specific smoking behaviors in West Virginia are not well documented in the literature. In
the Appalachian region, cigarette smoking is approximately 3.7% higher than the national
average (Appalachian Regional Commission, 2017). In 2018, the highest percentage (24.7%) of
adults smoking in West Virginia came from rural settings (United Health Foundation, 2019).
Those with a lower annual income also had the greatest percentage of adult smokers, with the
majority at less than $50,000 (United Health Foundation, 2019). Additionally, the highest
percentage (40.3%) of adult smokers had achieved less than a high school education (United
Health Foundation, 2019).
Smoking Cessation
In the United States, nicotine dependence is the leading cause of preventable disease and
death (Himelhoch, Riddle, & Goldman, 2014). Addiction to cigarettes is measured by nicotine
dependence, and differing levels of nicotine dependence affect smoking cessation success.
According to the DSM-IV, nicotine withdrawal is a syndrome that has four symptoms: nicotine
use immediately after waking, use of nicotine to avoid withdrawal symptoms, use of nicotine
after being in a situation where it was prohibited, and waking from sleep to use nicotine
(Goodwin et al., 2012). For adults, specific factors have also been identified as predictors of
abstinence: “age, marital status, education level, nicotine dependence, years of smoking,
previous quit attempts, prior smoking abstinence, time spent among smokers, smoking cessation
motivation, stage of change, self-efficacy, social support, depressive symptoms, and psychiatric
comorbidity” (Christenhusz, Pieterse, Seydel, & van der Palen, 2007).
Numerous smoking cessation resources are available and cost effective for patients (Ho,
Alnashri, Rohde, Murphy, & Doyle, 2015). Primarily, nicotine replacement therapy (NRT) is
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used to treat nicotine withdrawal. The administration of NRT delivers low concentrations of
nicotine to individuals trying to achieve cessation. It is available in many different forms, such as
gum, lozenge, transdermal patch, nasal spray, and inhaler. Cessation counseling is also available
for this population and predominantly targets behavioral therapy and/or motivational
interviewing (Prochaska et al., 2017). Tobacco quitlines are another resource available to
smokers. Tobacco quitlines are telephone services that offer both counseling and assistance with
NRT. Every state in the United States has a tobacco quitline that offers these services free of
charge. Only 8% of smokers trying to achieve cessation in the United States are aware of the
quitline and utilize the free resource (Prochaska et al., 2017).
Current delivery of cessation resources primarily requires healthcare providers to address
smoking with patients, or patients have to request smoking cessation treatment (Japuntich et al.,
2018). Historically, these programs have been most effective for educated individuals and
individuals without complicating factors, such as a psychological and behavioral health diagnosis
(Lawrence, Hafekost, Hull, Mitrou, & Zubrick, 2013). With time constraints during healthcare
visits, smoking is often not addressed. This care delivery method has proven to be ineffective
with psychological and behavioral healthcare providers, as they have the lowest cessation
treatment rates among healthcare providers (Japuntich et al., 2018). In the United States, the
prevalence of smoking is not evenly distributed, and disparities exist in the population (Steinberg
et al., 2015).
Smoking Cessation and COPD
COPD patients are typically lifetime smokers who attempt smoking cessation multiple
times without success (Christenhusz, Prenger, Pieterse, Seydel, & van der Palen, 2012). Smoking
cessation is said to be the most important factor for slowing the progression of COPD (Jonsdottir
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et al., 2015). Cessation aids in maintaining lung function in this population (Christenhusz et al.,
2012). Since COPD cannot be cured, smoking cessation reduces COPD symptoms, such as
sputum production and coughing. It also reduces exacerbations of COPD and improves quality of
life (Christenhusz et al., 2007; Christenhusz et al., 2012).
Smoking Cessation and Psychological and Behavioral Health
A psychological and behavioral health diagnosis affects smoking cessation success.
Those with a psychological and behavioral health diagnosis are considered the largest and most
vulnerable subgroup among smokers (Shi, 2014). Individuals with a psychological and
behavioral health diagnosis have lower cessation rates than the general population. Possible
rationales for the lack of success with cessation in this population include decreased motivation,
underutilization of available treatments, and greater relapse potential (Shi, 2014). Factors that
have been identified as barriers to smoking cessation for those with a psychological and
behavioral health diagnosis include mood irregularities, drug and alcohol use, high levels of
nicotine dependence, and poor social support (El-Mallakh et al., 2016).
One study examined smoking cessation characteristics among smokers receiving
psychological and behavioral health treatment. The study reported that compared to the general
population, those with a psychological and behavioral diagnosis have a similar number of quit
attempts. This indicates that lack of motivation may not be as significant when considering
barriers. Smokers who sought psychological and behavioral health treatment were less likely to
live in a smoke-free house but more likely to use cessation treatments than the general
population. Nicotine replacement therapy was used frequently, but the use of counseling,
quitlines, and support groups was rare. Based on this information, it could be inferred that this
population needs greater social support due to their high nicotine levels. The relationship
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between smoking and a psychological and behavioral health diagnosis is prevalent in the
literature; however, the relationship between psychological and behavioral health diagnoses and
smoking cessation is unclear (Shi, 2014).
Historically, smoking was widely accepted in the psychological and behavioral health
community (Shi, 2014). This was under the premise that nicotine was a self-medication for those
with a psychological and behavioral health diagnosis which lessened psychiatric symptoms
(Prochaska et al., 2017). This premise contributes to hesitation by patients and practitioners that
cessation of nicotine could lead to worsened psychiatric symptoms and behavioral health
outcomes. In the 1990s, fewer than 15% of patients in the outpatient psychiatric care setting were
informed about cessation options (Shi, 2014).
It is now known that nicotine withdrawal mimics symptoms of psychological and
behavioral health diagnoses. Nicotine withdrawal contributes to depressive symptoms, anxiety
symptoms, irritability, and restlessness, all of which can be relieved by smoking (Taylor,
McNeill, & Aveyard, 2015). This physiological process deceives individuals to believe that
smoking is benefiting their psychological and behavioral health. To be successful at smoking
cessation, individuals need to overcome the psychological withdrawal symptoms of tobacco
(Taylor et al., 2015). Once these symptoms are overcome, psychological and behavioral health
does improve for the majority of individuals (Taylor et al., 2015). Individuals who achieve
cessation for five years or greater report not only better psychological and behavioral health, but
also better physical and overall health (Floyd, Mallow, & Theeke, 2018). For those who do not
experience improved psychological and behavioral health, research reports that there is no
association between poor psychological and behavioral health post cessation and smoking
relapse (Taylor et al., 2015).
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Within the last ten years, studies continued to report that smoking was not being
addressed in facilities designed for psychiatric care. A study examined barriers to smoking
cessation implementation in psychological and behavioral health facilities and reported that 23%
of clinicians believed cessation would increase psychiatric symptoms, and 43% of clinicians
reported being unsure about this outcome (Himelhoch et al., 2014). The flawed self-medication
hypothesis is still identified as a substantial barrier to smoking cessation for both persons with a
psychological and behavioral health diagnosis and healthcare providers (Prochaska et al., 2017).
Readiness to Change
COPD
COPD is the third leading cause of death in the world. Predictors of mortality in the
COPD poulation inculde “air-flow limitation, hypercapnia, hypoxemia, low exercise capacity,
smoking habits, dyspnea, low body mass index, a high BODE (body mass index, obstruction,
dyspnea, exercise capacity) index, and exposure to biomass smoke” (Lou et al., 2014).
Approximately one third of persons with COPD continue to smoke, yet smoking is identified for
causing 80% of COPD deaths (Hilberink, Jacobs, Bottema, de Vries, & Grol, 2005; Ho et al.,
2015). In smokers, the highest incidence of COPD (35.5%) was found in those who smoke
continously, whereas the incidence of COPD in those who never smoked is only 7.8% (Lou et
al., 2014). Similiarly, in a sample of COPD patients, 24.8% reported being every day smokers,
7.7% reported being some day smokers, and 42.7% reported being former smokers. However, in
this sample, the percentage of never smokers with COPD was higher at 24.8% (Floyd et al.,
2018).
In the COPD population, motivation to achieve smoking cessation is related to smoking
behaviors. The more years patients smoke, the less motivated they are to quit. The more
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cigarettes they smoke in a day, the more motivated they are to quit (Bjarnason, Mikkelsen, &
Tønnesen, 2010). It is assumed that patients who smoke fewer cigarettes are dependent on those
few cigarettes and are less likely to achieve abstinence (Christenhusz et al., 2007). Perception of
their disease also contributes to their lack of cessation. A lack of knowledge related to the
harmful effects of smoking and its relation to COPD serves as a barrier to smoking cessation
treatment (Bjarnason et al., 2010).
A study on individualized counseling for patients with early COPD found four predictors
of cessation. Cessation was statitically significant with age, body mass index (BMI), attitude, and
pharmacotherapy. If smokers had a higher BMI and were older in age, they were more likely to
achieve cessation. A positive attitude toward smoking cessation was also a positive predictor of
cessation (Toljamo et al., 2010).
Depression
Depression affects treatment adherence and increases mortality (Lou et al., 2014).
Depressed patients are three times more likely to be noncompliant with medications, diet and
exercise, vaccinations, health behaviors, and medical appointments (G. Alexopoulos et al.,
2016). Having depression as a comorbidity impacts patients’ readiness to change. Smoking can
become a coping mechanism for patients with depression; therefore, patients with depressive
symptoms consistently have a reduced probability of achieving smoking cessation (Lou et al.,
2014). Individuals with depression are typically lifetime smokers and smoke more cigarettes than
those without depression (Michal et al., 2013). A study looking at psychological and behavioral
health diagnoses and smoking status in a community found that each cigarette smoked per day
increased the likelihood of developing depression by 3% (Michal et al., 2013). There is a
negative association between depressive symptoms and smoking cessation (Ho et al., 2015).
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COPD and Depression
The COPD population is not homogeneous. A common comorbidity of COPD is
depression. Compared to other chronic diseases, the prevalence of depression is higher in the
COPD population (Matte et al., 2016). Smoking, COPD, and depression are interrelated (Matte
et al., 2016). COPD and depression share common symptoms, such as poor sleep patterns, lack
of interest in life, decreased energy level, and decreased physical activity (Matte et al., 2016). In
the COPD population, the prevalence of depression is estimated at 40%; however, depression is
missed by practitioners in approximately 50% of patients, and only 40% of those diagnosed with
depression receive treatment (Yohannes et al., 2011).
The relationship between COPD and depression is bidirectional. The diagnosis of COPD
causes individuals to experience increased stress levels (Bratek et al., 2015). Patients with COPD
often experience differing forms of loss and social isolation as a result of their disease (Lou et
al., 2014; Matte et al., 2016). COPD increases the risk of developing depression, and depression
increases the risk of developing COPD (Matte et al., 2016). Depression affects initiation and
maintenance of smoking, and smoking causes COPD. However, few studies report the
relationship between depression and smoking status in respiratory patients (Ho et al., 2015).
One study found that 72% of patients with a diagnosis of COPD and depression refused
antidepressant medications (Alexopoulos et al., 2014). Due to the stigma, many psychiatric
patients deny their psychiatric diagnosis (Bratek et al., 2015). The highest rates of depression in
the COPD population are commonly seen in those post-exacerbation or those requiring oxygen
therapy. Depression is commonly correlated with COPD severity and the physical impairments
and social isolation associated with COPD severity (Matte et al., 2016).
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There is a need to identify smokers in vulnerable groups within the psychological and
behavioral health population. Inequalitites between those with psychological and behavioral
health diagnoses and the general population will continue to grow, unless disparities in smoking
prevalence are identified (Richardson et al., 2019). Patients with COPD and depression require
variability in treatment. Depression affects self-management and the compliance needed for
COPD treatment (Yohannes et al., 2011). Despite previously conceived beliefs, cessation does
improve psychological and behavioral health (Ho et al., 2015). Factors that influence smoking
behaviors and readiness to change need to be examined to address the complex healthcare needs
of patients with COPD and depression. Exploring factors in this population can help develop
personalized cessation interventions (Richardson et al., 2019).
Theoretical Framework
The Transtheoretical Model was created in the field of psychology by James Prochaska
and Carlo DiClemente. The model emerged during a time when psychotherapy had grown into a
field with more than 300 theories (Prochaska & Velicer, 1997). Prochaska and DiClemente
(1982) conducted a comparative analysis of the 18 leading therapies during that time. In their
work, Prochaska and DiClemente (1982) noted that transtheoretical therapy was moving towards
a model of change. They found that all the theories do not use differing change processes;
instead, they suggested there were five processes of change (Prochaska & DiClemente, 1982). It
is from this original work that the ten processes of change are now conceptualized as
consciousness raising, dramatic relief, self-reevaluation, environmental reevaluation, selfliberation, social liberation, counterconditioning, stimulus control, contingency/reinforcement
management, and helping relationships (Prochaska & Velicer, 1997).
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Stages of change then emerged from DiClemente and Prochaska’s (1982) work on
smoking behavior. DiClemente and Prochaska (1982) sought to compare the processes of change
in participants who achieved cessation on their own to those who attended programs for
cessation. In this study, it was found that each group went through a sequence of stages before
implementing change (DiClemente & Prochaska, 1982). This finding revealed that behavior
change progresses through a series of stages (Prochaska & Velicer, 1997). It is from this original
work that the five stages are now conceptualized as precontemplation, contemplation,
preparation, action, and maintenance (Prochaska & Velicer, 1997).
The processes of change and stages of change were then integrated together (Prochaska
& DiClemente, 1982). From studying self-changers and therapy changers, it became apparent
that certain processes of change were used during certain stages of change. Verbal processes of
change are used more often at the beginning stages of change, whereas behavioral processes of
change are used more when individuals are ready to act. Once individuals are committed to
action, behavioral therapies play a more important role than verbal therapies (Prochaska &
DiClemente, 1982). These processes of change are critical in developing interventions for
individuals as they progress through the stages of change (Prochaska & Velicer, 1997).
Basic principles apply for progressing through the stages using decisional balance. When
moving from precontemplation to contemplation, the benefits of change outweigh the
consequences. When moving from contemplation to action, the consequences must decrease. The
benefits must outweigh the consequences for action to occur. Statistical analysis shows the
benefits must increase twice as much as the consequences decrease for change to occur
(Prochaska & Velicer, 1997).
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How the Theory Has Been Used
Prochaska and DiClemente (1982) created the Transtheoretical Model while studying
smoking behavior. The model has been widely used to study smoking behaviors, but it has also
been used to study other subjects, such as anxiety, substance abuse, eating disorders, AIDS
prevention, mammography screening, pregnancy prevention, radon testing, obesity, and many
more health behaviors (Prochaska & Velicer, 1997).
Smoking and The Transtheoretical Model
It is important to know the stage distribution of certain populations. A series of studies on
the smoking population supports that 40% of smokers are in the pre-contemplation stage, 40% of
smokers are in the contemplation stage, and approximately 20% of smokers are in the
preparation stage. This distribution contributes evidence that action-oriented programs are not
efficient for this population (Prochaska & Velicer, 1997).
Prochaska and DiClemente (1983) tested the Transtheoretical Model on 872 participants
trying to achieve cessation without seeking treatment. In this smoking population, it was found
that the processes of change were rarely used in the precontemplation stage. This is a consistent
finding within the Transtheoretical Model literature. It is believed that smokers in the
precontemplation stage do not comprehend smoking information, they do not reevaluate
themselves, they have fewer emotional responses about the consequences of smoking, and they
make fewer attempts to change their atmosphere or attentiveness away from smoking. When
smokers are in the contemplation stage, they are more responsive to smoking education and
feedback. It is also in the contemplation stage that smokers reevaluate themselves. This
reevaluation often turns into action as individuals become upset with their behavior and make a
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commitment to change. Participants then use the processes, counterconditiong, and stimuluscontrol during the action stage (Prochaska & DiClemente, 1983).
How the Theory will Guide this Study
The core constructs of the Transtheoretical Model will guide this study. The stages of
change, the processes of change, and decisional balance will be used to explore factors
influencing smoking behaviors and readiness to change for patients with comorbid COPD and
depression. The Transtheoretical Model assumes that the majority of at-risk populations are not
ready to take action. (Prochaska & Velicer, 1997). Patients with comorbid COPD and depression
are an at-risk population. The Transtheoretical Model construct will guide knowledge
development on the stage distribution of patients with COPD and depression, what processes of
change they use, and how decisional balance influences their progression through the stages of
change.
Summary
There is a need to recognize the changing demographics among the smoking population.
Targeting subgroups and developing innovative tobacco control is of the utmost importance
(Lawrence et al., 2013). The purpose of this study was to explore and describe factors
influencing smoking behaviors and readiness to change in patients with comorbid COPD and
depression. The purpose was developed through the research question, aims, and the theoretical
framework. The research question guided the methodology that will be presented in Chapter 3.
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Chapter Three: Methods
The purpose of this study was to explore and describe factors influencing smoking
behaviors and readiness to change in patients with comorbid COPD and depression. The research
design, human subject protection, sampling method, study variables, instruments,
procedures/data collection, and plan for data analysis will be discussed in this chapter.
Research Design
The research question directed the methodology for inquiry (Polit & Beck, 2017). For
this study, a descriptive cross-sectional design was used to answer the question, “What are the
relationships among smoking, COPD, and depression?” The following aims stemmed from the
research question:
•

Aim 1: To describe the characteristics of a convenience sample of people living with
COPD and differing categories of depression who sought care in West Virginia.

•

Aim 2: To describe the differences between people with COPD and differing categories
of depression (minimal, mild, moderate, moderately severe, severe, or no depression)
related to smoking behaviors and readiness to change.

•

Aim 3: To explore the relationships among COPD, depression, smoking behaviors, and
readiness to change.

•

Aim 4: To analyze the relationships among COPD, depression, smoking behaviors, and
readiness to change.

A descriptive cross-sectional design is intended to observe, describe, and record a situation while
it is occurring (Polit & Beck, 2017). Smoking behaviors and readiness to change were described
for patients with COPD while comparing differing categories of depression. The aims then aided
in further describing the population.

27
Human Subject Protection
Informed Consent
A formal protocol was submitted to West Virginia University’s Institutional Review
Board (IRB) for approval. The study was classified as exempt and did not require documentation
of informed consent. Participation in the study was voluntary. Participants read a cover letter and
were made aware that they had the right to withdraw from the study at any point. A $10 gift card
to Walmart was used as an incentive for participation.
Privacy and Confidentiality
Privacy was ensured to the participants throughout the study. Most participants
completed the survey from home, submitting it either electronically or by mail. A few
participants completed the survey on a tablet device in the waiting room of their provider’s
office. Screen protectors were placed on the tablets to ensure privacy. Once the surveys were
completed, the compiled data was deidentified to ensure confidentiality.
Risks and Benefits
Prior to conducting a study, benefits of participating in the study must outweigh the risks.
Participating in this study did not interfere with the care participants received from their
healthcare provider. Risks associated with this study were minimal. Potential existed that the
survey questions could trigger an emotional response from the participants. If this did occur,
participants were provided a referral list that included the phone numbers for WVU Family
Medicine, WVU COPD Clinic, WVU Behavioral Medicine and Psychiatry, and the National
Suicide Hotline.
Benefits of participating in the study included participants’ satisfaction in knowing they
were contributing to knowledge development. Knowledge gained from the research findings
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could benefit other individuals with COPD and depression. These findings have the potential to
impact policy and the clinical management of individuals with COPD and depression. These
findings can also lead to future studies aiming to improve patient outcomes for individuals with
COPD and depression.
Ethical Principle: Respect for Persons
The principle of respect for persons requires permission from participants prior to
engaging in research. This principle relates directly to informed consent. Informed consent
includes information disclosure, voluntariness, and understanding. Respect for persons protects
participants’ autonomy and dignity. It also ensures that participants are able to withdraw from
the study at any point, without fear of repercussions (Beauchamp, 2008; Emanuel, Wendler, &
Grady, 2008). This study was classified as exempt and did not require documentation of
informed consent. Participation in the study was voluntary. Participants read a cover letter and
were made aware that they had the right to withdraw from the study at any time.
Ethical Principle: Beneficence
The principle of beneficence guards each participant from harm. More specifically, the
benefits of the research should be abundant while risks are minimal (Beauchamp, 2008). The
risks of participating in the study were assessed and minimized. The risks associated with this
study were minimal. Potential existed that the survey may stimulate an emotional response from
the participants or that completing the survey may cause the participants to experience fatigue.
After completing the survey, participants were provided a referral list that included the phone
numbers for WVU Family Medicine, WVU COPD Clinic, WVU Behavioral Medicine and
Psychiatry, and the National Suicide Hotline. Participants were made aware that they could
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withdraw from the study at any point. Benefits of participating in the study included participants’
satisfaction in knowing they were contributing to knowledge development.
Ethical Principle: Justice
The principle of justice demands that the burdens and benefits of research are fairly
distributed. This principle protects vulnerable populations and promotes proper selection of
research participants. Justice requires researchers to select participants who are capable of
bearing the burdens of research instead of targeting the same population repeatedly (Beauchamp,
2008).
Appropriate steps were taken to ensure the ethical principle of justice was not breached.
The population was assessed for vulnerability. Living in a rural location, being of a lower
socioeconomic class, and having minimal education are all factors that can be considered health
disparities. The researcher was sensitive to the fact that these disparities could contribute to the
vulnerability of this population. The scientific reason for choosing this population was due to the
high prevalence of COPD in West Virginia.
Sample
This study used a convenience sample to recruit participants. This sampling method
selects participants who are readily available to participate in the study (Polit & Beck, 2017).
G*Power software version 3.0.10 was used to calculate the sample size needed to adequately
power the following aims: to describe the characteristics of a convenience sample of people
living with COPD and differing categories of depression who sought care in West Virginia; to
describe the differences between people with COPD and differing categories of depression
(minimal, mild, moderate, moderately severe, severe, or no depression) related to smoking
behaviors and readiness to change; to explore the relationships among COPD, depression,
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smoking behaviors, and readiness to change; and to analyze the relationships among COPD,
depression, smoking behaviors, and readiness to change. In order to detect a difference between
two groups with two independent means with an effect size of d = 0.5 (medium), α = 0.05, power
= 1-β = 0.8, a sample of N = 130 participants was needed to reach adequate power. Participants
were included in the study if they were adults greater than 18 years of age, self-reported a
diagnosis of COPD, self-reported being able to read English at a 6th grade level, and self-reported
being a current or former smoker. Participants were excluded from the study if they were less
than 18 years of age, unable to read English at a 6th grade level, never smoked, or did not selfreport a diagnosis of COPD.
Study Variables and Instruments
Demographic Variables
Demographic variables were collected on the population. Information collected included
participants’ education level, age, gender, income, race, and comorbid conditions. Participants
were also asked the questions, “Do you have depression?” and “Do you take medications to treat
depression?” The variable, “Do you have depression?” will be referred to as “self-reported
depression” throughout this study. The variable, “Do you take medications to treat depression?”
will be referred to as “medication for depression” throughout this study.
Smoking Behaviors
Smoking behaviors are conceptually defined as patients’ smoking status, frequency of
use, and nicotine dependence. These smoking behaviors were measured using The Cigarette
Dependence Scale (CDS-12). Participants only completed this tool if they were current smokers.
The CDS-12 is a self-administered tool that provides a continuous measurement of cigarette
dependence for daily and occasional cigarette smokers (Etter, Le Houezec, & Perneger, 2003).
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The CDS-12 is a 12-item instrument. The sum of the items are calculated, and the level of
cigarette dependence varies from 12, the lowest level of dependence, to 60, the highest level of
dependence. Within the tool, participants’ frequency of use is addressed by asking the question,
“On average, how many cigarettes do you smoke per day?” The CDS-12 is reported to be a valid
and reliable tool with psychometric testing of test-retest correlation of > 0.60 for all items and >
0.83 overall. Internal consistency is high with Cronbach’s alpha > 0.84 (Etter et al., 2003).
Readiness to Change
Readiness to change is conceptually defined as the perceived stage, pros and cons, and
situations and thoughts that occur in the processes of change that affect smoking habits. The
Smoking Stage of Change Questionnaire, The Smoking Decisional Balance Questionnaire, and
The Processes of Change Questionnaire were used to operationalize readiness to change.
Smoking Stage of Change Questionnaire
The perceived stage of change was measured by The Smoking Stage of Change
Questionnaire, which is a three-item instrument. This questionnaire works as an algorithm, and
depending on responses, participants were categorized in a stage of change. If participants had
quit smoking within the last six months, they were placed in the action stage. If participants had
quit more than six months ago, they were placed in the maintenance stage. If participants were
thinking about quitting in the next 30 days and had one 24-hour quit attempt in the past year,
they were placed in the preparation stage. If participants were thinking about quitting in the next
30 days and had no quit attempt in the past year, they were placed in the contemplation stage. If
participants were thinking of quitting in the next six months, they were also placed in the
contemplation stage. If participants were not thinking of quitting, they were placed in the
precontemplation stage. There is no formal psychometric data to support this instrument;
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however, this instrument was specifically derived from the concepts of the Transtheoretical
Model.
Smoking Decisional Balance Questionnaire
The pros and cons of smoking were measured by The Smoking Decisional Balance
Questionnaire. The Smoking Decisional Balance Questionnaire is a 20-item instrument that uses
a 5-point likert scale. Participants were asked to rate the importance each statement had on their
decision to smoke. Selecting 1 indicated not important at all, and selecting 5 indicated extremely
important. Items were added and averaged to produce two subscales, pros of smoking and cons
of smoking. The difference of the scores can be calculated by subtracting the cons of smoking
from the pros of smoking. If the difference is positive, the participants saw more pros of
smoking. If the difference is negative, the participants saw more cons of smoking. The Smoking
Decisional Balance Questionnaire is supported to be a valid and reliable tool with reliability
Cronbach alphas of 0.87 (pros) and 0.90 (cons) (Velicer, DiClemente, Prochaska, &
Brandenburg, 1985).
The Processes of Change Questionnaire
The situations and thoughts that affect smoking habits were measured by The Processes
of Change Questionnaire. The Processes of Change Questionnaire is a 20-item instrument.
Participants were asked to rate how often the listed experiences or events had happened to them
in the last month. Participants rated their responses from 1 (never) to 5 (repeatedly). The sum of
all the scores gives a mean processes of change score, with a higher score indicating engagement
in the processes of change. The means of the processes of change subscales were also calculated.
The Processes of Change Questionnaire is a valid and reliable tool, with reliability Cronbach
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alphas of 0.69-0.92 for each of the 10 subscales (Prochaska, Velicer, DiClemente, & Fava,
1988).
COPD
The diagnosis of COPD was initially self-reported by participants. Participants were
asked if they ever received a diagnosis of COPD from a healthcare provider. If participants
responded “yes,” then they had COPD. If participants responded “no,” then they did not have
COPD. If participants were unable to answer with certainty, then they did not have COPD for
this study. Due to a low response rate, other recruitment strategies were used to identify
participants with COPD. Those that had a diagnosis of COPD in their electronic medical record
received mailings about the research study. Also, physicians and nurse practitioners aided in
identifying patients with COPD.
Depression
Depression was assessed by using the PHQ-9. The PHQ-9 is a 10-item questionnaire.
Participants were asked, “Over the last two weeks, how often have you been bothered by any of
the following problems?” Participants rated their responses from 0 (not at all) to 3 (nearly every
day). The participants total score was then calculated, with a higher score indicating more severe
depression. A score of 1-4 indicated minimal depression, a score of 5-9 indicated mild
depression, a score of 10-14 indicated moderate depression, a score of 15-19 indicated
moderately severe depression, and a score of 20-27 indicated severe depression. The PHQ-9 is
supported to be a valid instrument with Cronbach alphas of 0.86-0.89 and test-retest reliability
with a correlation of 0.84 (Kroenke, Spitzer, & Williams, 2001).
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Procedures and Data Collection
Recruitment methods were multifaceted. Primary recruitment was first conducted face-toface at Family Medicine at WVU Medicine University Town Centre. The researcher and a
research assistant approached potential participants in the waiting room with a flyer advertising
the study. If patients met the inclusion criteria and elected to participate, they completed the
survey via a tablet in the waiting room. Due to the COVID-19 pandemic, face-to-face
recruitment occurred for one month and then was suspended.
During the COVID-19 pandemic, a study mailing was conducted from a list of COPD
patients provided by Family Medicine at WVU Medicine University Town Centre. The patients
received the study flyer and cover letter. Patients then contacted the researcher to participate in
the study. Other recruitment strategies during this time included study advertisement through
local and statewide clinics and WVU Medicine. The study flyer was placed in clinic waiting
rooms, WVU’s pulmonary function test lab, and WVU’s emergency room waiting room. Nurse
navigators, case managers, and the COPD educator at WVU Medicine were also promoting the
study to patients. A newspaper advertisement for the study was also ran through the Dominion
Post in Morgantown, West Virginia.
Once permitted, face-to-face recruitment resumed and was conducted at the Pulmonary
Clinic at WVU Physician Office Center. COPD patients were identified by the providers and the
researcher spoke to the patients after being seen by the provider. If patients met the inclusion
criteria and elected to participate, they provided the researcher with their home address or email
address, depending on their preference for completing the survey. A second mailing was also
conducted from a list of COPD patients provided by the Pulmonary Clinic at WVU Physician
Office Center. The patients received a paper copy of the survey with a prepaid return envelope. If
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patients met the inclusion criteria and elected to participate, they completed the survey and
mailed it back to the researcher.
Plan for Data Analysis
Deidentified data was statistically analyzed using the Statistical Package for the Social
Sciences 26 (SPSS). Prior to analyzing the data, the quality of the data was explored and cleaned
based on variable type and appropriate statistical techniques to ensure accurate results.
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia. To describe the sample,
descriptive statistics were run on the demographic variables and the PHQ-9 results. Categorical
variables were analyzed by frequency distribution tables, and continuous variables were analyzed
by range, means, percentiles, medians, and standard deviations.
To describe the total sample based on the key variables, descriptive statistics were run on
The Cigarette Dependence Scale, The Smoking Decisional Balance Questionnaire, The
Processes of Change Questionnaire, The Processes of Change Questionnaire Sub-Scales, and
The Smoking Stage of Change Questionnaire. Categorical variables were analyzed by frequency
distribution tables, and continuous variables were analyzed by range, means, percentiles,
medians, and standard deviations.
One-way analysis of variance, chi-square test for independence, Pearson correlation, and
t-tests were conducted to explore and describe the relationship among the variables based on the
variable type. The researcher hypothesized that the demographic data would be similar to a
sample of patients with COPD from West Virginia but different from a national sample of
patients with COPD. The researcher also hypothesized that there would be at least one
statistically significant covariate identified for a dependent variable.
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To describe the differences between people with COPD and differing categories of
depression (minimal, mild, moderate, moderately severe, severe, or no depression) related to
smoking behaviors and readiness to change. One-way analysis of variance was used to analyze
The Cigarette Dependence Scale, The Smoking Decisional Balance Questionnaire, and The
Processes of Change Questionnaire based on the categories of depression. Chi-square for
independence was used to compare the differences between The Smoking Stage of Change
Questionnaire for those with COPD only and those with COPD and depression. The researcher
made the following hypotheses: participants with increased levels of depression would have a
higher level of cigarette dependence and would be less ready to implement change; participants
with depression would report being in the precontemplation and contemplation stage;
participants without depression would report being in the contemplation and preparation stage.
To explore the relationships among COPD, depression, smoking behaviors, and
readiness to change. To analyze this aim, sub-aims were created.
•

To describe the relationship among COPD, depression, and The Cigarette Dependence
Scale. Pearson correlation was used to describe the relationships among COPD,
depression severity, and The Cigarette Dependence Scale. The researcher hypothesized
that participants with higher depression severity would report a higher level of cigarette
dependence.

•

To describe the relationship among COPD, depression, and The Smoking Decisional
Balance Questionnaire. Pearson correlation was used to describe the relationships among
COPD, depression severity, and The Smoking Decisional Balance Questionnaire. The
researcher hypothesized that participants with higher depression severity would report
more pros for smoking than cons.

37
•

To describe the relationship among COPD, depression, and The Processes of Change
Questionnaire. Pearson correlation was used to describe the relationships among COPD,
depression severity, and The Processes of Change Questionnaire. The researcher
hypothesized that participants with higher depression severity would not report use of
processes of change.
To analyze the relationship among COPD, depression, smoking behaviors, and readiness

to change. A linear regression was used to analyze variables that had a statistically significant
association among The Smoking Stage of Change Question, The Cigarette Dependence Scale,
The Smoking Decisional Balance Questionnaire, and The Processes of Change Questionnaire. A
multiple linear regression was used to control for key study variables if they had a significant
bivariate relationship with the dependent continuous variables. No hypotheses were created due
to the unknown statistical significance of the variables.
Feasibility of Proposed Research
This study was feasible due to the prevalence of COPD, smoking, and depression in the
state of West Virginia. Family Medicine and the Pulmonary Clinic at WVU Medicine both treat
COPD patients and offer COPD clinics. With a large portion of West Virginia residents seeking
care from WVU Medicine, recruitment was deemed possible. A $10 gift card to Walmart was
also used as an incentive for patient participation.
Conclusion
To explore and describe factors influencing smoking behaviors and readiness to change
in patients with comorbid COPD and depression, a descriptive cross-sectional design was used.
Human subjects were protected, and the ethical principles of respect for persons, beneficence,
and justice were not breached. A convenience sample was recruited, and the study variables were
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measured using valid and reliable instruments. Data collection and data analysis were then
conducted to answer the research question and aims.
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Chapter Four: Results
Aim 1: To Describe the Characteristics of a Convenience Sample of People Living with
COPD and Differing Categories of Depression who Sought Care in West Virginia
Descriptive Statistics on Demographic Variables
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, descriptive statistics were
run on the demographic variables. In this study the total sample size was 222 participants. Of the
222 participants, 108 were males (48.6%) and 112 were females (50.5%). Their ages ranged
from 32-94 years old with a mean age of 64 years old (SD = 9.6). Half of the sample (50%) had
an income
< $24,000, and the vast majority were white (95%). The highest level of education completed
varied among the sample, with the majority either completing high school (30.2%) or attending
some college (23%). Diabetes mellitus (14.4%) was the most frequent comorbid condition,
followed by congestive heart failure (9%). In this sample, 113 participants (50.9%) stated they
did not have depression, and 101 participants (45.5%) stated they did have depression. When
asked if they took medications to treat depression, 133 participants (59.9%) reported no, and 79
participants (35.6%) reported yes.
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Descriptive Statistics: Categorical Demographic Variables
Variable

N (%)

Gender
Male

108 (48.6)

Female

112 (50.5)

Income
<$24,000

111 (50)

$25,000-$49,999

56 (25.2)

$50,000-$74,999

25 (11.3)

$75,000-$99,999

11 (5)

>$100,000

10 (4.5)

Race
White

211 (95)

Black

4 (1.8)

Hispanic

2 (0.9)

Other

1 (0.5)

Education Level
No formal education

1 (0.5)

Completed elementary

3 (1.4)

Some high school

30 (13.5)

Completed high school

67 (30.2)

Some college

51 (23)

Associate degree

18 (8.1)

Bachelor’s degree

17 (7.7)

Master’s degree

7 (3.2)

Other

7 (3.2)

GED

18 (8.1)
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Comorbid conditions
Myocardial infarction

17 (7.7)

Congestive heart failure

20 (9)

Peripheral vascular disease

18 (8.1)

Cerebral vascular accident/TIA

8 (3.6)

Dementia

4 (1.8)

Connective tissue disease

1 (0.5)

Peptic ulcer disease

6 (2.7)

Liver disease

12 (5.4)

Diabetes mellitus

32 (14.4)

Hemiplegia

1 (0.5)

Moderate to severe chronic kidney disease

5 (2.3)

Solid tumor

3 (1.4)

Leukemia

0 (0)

Lymphoma

3 (1.4)

AIDS

2 (0.9)

Do you have depression?
No

113 (50.9)

Yes

101 (45.5)

Do you take medications to treat depression?
No

133 (59.9)

Yes

79 (35.6)

Descriptive Statistics: Continuous Demographic Variables
Variable
Mean
Range
Age

64

32-94

Standard Deviation
9.6
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Descriptive Statistics on the PHQ-9
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, descriptive statistics were
run on the PHQ-9 results. Depression severity ranged from 0-27, with a mean of 7.9 (SD = 6.4).
For this sample, 18 participants (8.1%) were classified as having no depression, 59 participants
(26.6%) were classified as having minimal depression, 52 participants (23.4%) were classified as
having mild depression, 39 participants (17.6%) were classified as having moderate depression,
25 participants (11.3%) were classified as having moderately severe depression, and 12
participants (5.4%) were classified as having severe depression.
Descriptive Statistics: PHQ-9
Variable

N (%)

No depression

18 (8.1)

Minimal depression

59 (26.6)

Mild depression

52 (23.4)

Moderate depression

39 (17.6)

Moderately severe depression

25 (11.3)

Severe depression

12 (5.4)

Variable

Mean

Range

Standard Deviation

PHQ-9

7.9

0-27

6.4

Descriptive Statistics on The Cigarette Dependence Scale, The Processes of Change
Questionnaire, The Processes of Change Questionnaire Sub-Scales, The Smoking
Decisional Balance Questionnaire, and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, descriptive statistics were
analyzed on the key study variables. Scores for The Cigarette Dependence scale ranged from 23-
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54 with a mean score of 43.82. Scores for The Processes of Change Questionnaire ranged from
19.05-88.2 with a mean score of 45.8. Scores on The Smoking Decisional Balance Questionnaire
ranged from -30.4-21.4 with a mean score of -5.78. For The Processes of Change Questionnaire
Sub-Scales, participants used more experiential processes (23.65) than behavioral processes
(20.4). Social liberation was the most used process of change (4.72), and stimulus control was
the least used (2.56).
The Smoking Stage of Change Questionnaire results found that 87 participants (39.2%)
reported they currently smoked, 4 participants (1.8%) reported they quit within the last 6 months,
115 participants (51.8%) reported they quit more than 6 months ago, and 2 participants (0.9%)
reported they never smoked. When asked if those who smoked were thinking of quitting, 25
participants (11.3%) reported they wanted to quit within the next 30 days, 32 participants
(14.4%) reported they wanted to quit within the next 6 months, and 28 participants (12.6%)
reported they were not thinking of quitting.
The Smoking Stage of Change Questionnaire was also used to classify participants into
their perceived stage of change. In this study, 28 (12.6%) participants were in the
precontemplation stage; 39 (17.6%) participants were in the contemplation stage; 17 (7.7%)
participants were in the preparation stage; 4 participants (1.8%) were in the action stage; and 115
(51.8%) participants were in the maintenance stage.

44
Descriptive Statistics: The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
Variable
Mean
Range
Standard Deviation
Cigarette
Dependence Scale

43.82

23-54

7.97

Processes of Change
Questionnaire

45.8

19.05-88.2

15.89

Smoking Decisional
Balance
Questionnaire

-5.78

-30.4-21.4

10.81

Descriptive Statistics: The Smoking Stage of Change Questionnaire
Smoking Stage of Change
N (%)
Are you a current smoker?
Yes, I currently smoke

87 (39.2)

No, I quit within the last 6 months

4 (1.8)

No, I quit more than 6 months ago

115 (51.8)

No, I have never smoked

2 (0.9)

Are you seriously thinking of quitting smoking?
Yes, within the next 30 days

25 (11.3)

Yes, within the next 6 months

32 (14.4)

No, not thinking of quitting

28 (12.6)
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Descriptive Statistics: The Smoking Stage of Change Questionnaire
Smoking Stage of Change
N (%)
Precontemplation

28 (12.6)

Contemplation

39 (17.6)

Preparation

17 (7.7)

Action

4 (1.8)

Maintenance

115 (51.8)

Descriptive Statistics: The Processes of Change Questionnaire Sub-Scales
Variable
Mean
Range

Standard
Deviation

Behavioral process

20.4

9.1-42.4

7.96

Experiential process

23.65

9.1-43.3

8.02

Consciousness raising

4.3

1.5-7.5

1.77

Dramatic relief

3.48

1.5-7.5

1.68

Environmental
reevaluation

3.52

1.5-7.5

1.95

Self-reevaluation

3.48

1.5-7.5

1.88

Social liberation

4.72

1.5-7.5

1.82

Contingency/reinforcement
management

3.03

1.5-7.5

1.86

Counter conditioning

3.43

1.5-7.5

1.67

Helping relationships

3.66

1.5-7.5

1.97

Self-liberation

4.06

1.5-7.5

1.95

Stimulus control

2.56

1.5-7.5

1.64
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Education Level and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a one-way analysis of
variance (ANOVA) was conducted to explore the impact of education level on The Cigarette
Dependence Scale, The Smoking Decisional Balance Questionnaire, and The Processes of
Change Questionnaire. For normality of the data, education categories were collapsed to “less
than high school,” “high school/GED,” “some college,” and “associate/college graduate/other.”
There was no significant difference at the p < 0.05 level for The Cigarette Dependence Scale F
(3, 72) = 0.26, p = 0.85; The Processes of Change Questionnaire F (3, 132) = 2.05, p = 0.11; or
The Smoking Decisional Balance Questionnaire F (3, 122) = 1.03, p = 0.38.
ANOVA: Impact of Education Level on The Cigarette Dependence Scale, The Processes of
Change Questionnaire, and The Smoking Decisional Balance Questionnaire
Variable
Df
Sum of
Mean Square
F
p value
Squares
Cigarette
Dependence
Scale

3

51.65

17.22

0.26

0.85

Processes of
Change
Questionnaire

3

1519.16

506.39

2.05

0.11

Smoking
Decisional
Balance
Questionnaire

3

359.78

119.93

1.03

0.38

Education Level and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for

47
independence was used to explore the differences between income and the categories of The
Smoking Stage of Change Questionnaire. When asked, “Are you a current smoker?” the
categories “No, I quit within the last 6 months” and “No, I have never smoked” violated the
minimum cell frequency for chi-square analysis. Subsequently, the category “No, I quit within
the last 6 months” was collapsed with “No, I quit more than 6 months ago” and “No, I have
never smoked” was excluded from the analysis. Education categories were also collapsed to
“completed high school/some college” and “college degree/other” due to violating the minimum
cell frequency for chi-square analysis. The categories “no formal education,” “completed
elementary,” and “some high school” were excluded from the analysis. A chi-square test for
independence (with Yates’ Continuity Correction) indicated a statistically significant association
between education and the categories, “Yes, I currently smoke” and “No, I quit within the last 6
months/more than 6 months ago,” x² (1, n = 156) = 4.64, p = 0.03, phi = 0.02.
When asked, “Are you seriously thinking of quitting smoking?” the categories “Yes,
within the next 30 days” and “Yes, within the next 6 months” violated the minimum cell
frequency for chi-square analysis. Subsequently, these categories were collapsed together.
Education categories were also collapsed to “completed high school/some college” and “college
degree/other” due to violating the minimum cell frequency for chi-square analysis. The
categories “no formal education,” “completed elementary,” and some high school” were
excluded from the analysis. A chi-square test for independence (with Yates’ Continuity
Correction) indicated no significant association between education and the categories, “Yes,
within the next 30 days/6months” and “No, not thinking of quitting,” x² (1, n = 64) = 0.02, p =
0.88, phi = 0.63.
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Chi-Square Test for Independence: Differences Between Education Level and The Smoking
Stage of Change Questionnaire
Smoking Stage of Change Questionnaire
Are you a current smoker?
Education

Yes, I currently smoke

No, I quit within the last 6
months/more than 6 months ago

Completed high
school/some college

52 (47.7)

57 (52.3)

College degree/other

13 (27.7)

34 (72.3)

Are you seriously thinking of quitting smoking?
Education

Yes, within the next 30 days/6
months

No, not thinking of quitting

Completed high
school/some college

35 (68.6)

16 (31.4)

College degree/other

8 (61.5)

5 (38.5)

Age and The Cigarette Dependence Scale, The Processes of Change Questionnaire, and The
Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, Pearson correlation was
used to describe the relationship between age and The Cigarette Dependence Scale, The
Processes of Change Questionnaire, and The Smoking Decisional Balance Questionnaire.
Preliminary analyses were performed to ensure no violation of the assumptions of normality,
linearity, and homoscedasticity. There was a small, non-significant negative correlation between
age and The Cigarette Dependence Scale, r = -0.03, n = 76, p = 0.81. There was a statistically
significant small, negative correlation between age and The Processes of Change Questionnaire,
r = -0.2, n = 135, p = 0.02. There was a small, negative correlation between age and The
Smoking Decisional Balance Questionnaire, r = -0.02, n = 126, p = 0.79.
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Pearson Correlation: Age and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
Variable
Cigarette Dependence Processes of Change Smoking Decisional
Scale
Questionnaire
Balance
Questionnaire
Age

-0.03, p = 0.81

-0.2, p = 0.02

-0.02, p = 0.79

Age and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a one-way analysis of
variance (ANOVA) was conducted to explore the impact of age on The Smoking Stage of
Change Questionnaire. When asked, “Are you a current smoker?” there was a statistically
significant difference at the p < 0.05 level: F (3, 197) = 9.1, p = 0.00. The effect size calculated
using eta squared was 0.12. Post-hoc comparisons using the Tukey HSD test indicated that the
mean score for “Yes, I currently smoke” (M = 60.21, SD = 9.58) was significantly different from
“No, I quit more than 6 months ago” (M = 66.38, SD = 8.73). “Yes, I currently smoke” (M =
60.21, SD = 9.57) was also significantly different from “No, I have never smoked” (M = 78, SD
= 0.00). “No, I quit within the last 6 months” (M = 62.25, SD = 6.07) did not differ significantly
from any group.
When asked, “Are you seriously thinking of quitting smoking?” the results of the
ANOVA violated the assumption of homogeneity of variance (p = 0.04). The Robust Tests of
Equality of Means indicated no significant difference (p = 0.08).
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ANOVA: Impact of Age on The Smoking Stage of Change Questionnaire
Variable
Df
Sum of
Mean Square
F
Squares

p value

Are you a current smoker?
Age

3

Variable

2254.09

751.36

9.16

Df

.000

p value

Are you seriously thinking of quitting smoking?
Age

2

0.08

Gender and The Cigarette Dependence Scale, The Processes of Change Questionnaire, and
The Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, t-tests were conducted to
seek differences in The Cigarette Dependence Scale, The Smoking Decisional Balance
Questionnaire, and The Processes of Change Questionnaire based on gender. For The Cigarette
Dependence Scale, there was no significant difference in scores for males (M = 44.42, SD =
7.33) and females (M = 43.28, SD = 8.56; t (74) = 0.62, p = 0.54, two tailed). For The Smoking
Decisional Balance Questionnaire, there was no significant difference in scores for males (M = 4.21, SD = 11.77) and females (M = -7.34, SD = 9.59; t (124) = 1.64, p = 0.1, two tailed). For
The Processes of Change Questionnaire, there was a statistically significant difference in scores
for males (M = 41.36, SD = 13.82) and females (M = 50.38, SD = 16.66; t (134) = -3.44, p =
0.00, two tailed).
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T-Test: Differences between Gender and The Cigarette Dependence Scale, The Processes of
Change Questionnaire, and The Smoking Decisional Balance Questionnaire
Males
Females
Variables

Mean

SD

Mean

SD

t

p

Cigarette
Dependence
Scale

44.42

7.33

43.28

8.56

0.62

0.54

Processes of
Change
Questionnaire

41.36

13.82

50.38

16.66

-3.44

0.00

Smoking
Decisional
Balance
Questionnaire

-4.21

11.77

-7.34

9.59

1.64

0.1

Gender and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for
independence was used to explore the differences between categories of gender and the
categories of The Smoking Stage of Change Questionnaire. When asked, “Are you a current
smoker?” the categories “No, I quit within the last 6 months” and “No, I have never smoked”
violated the minimum cell frequency for chi-square analysis. Subsequently, the category “No, I
quit within the last 6 months” was collapsed with “No, I quit more than 6 months ago,” and “No,
I have never smoked” was excluded from the analysis. A chi-square test for independence (with
Yates’ Continuity Correction) indicated no significant association between gender and the
categories, “Yes, I currently smoke” and “No, I quit within the last 6 months/more than 6 months
ago,” x² (1, n = 206) = 0.37, p = 0.54, phi = 0.45.
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When asked, “Are you seriously thinking of quitting smoking?” a chi-square test for
independence (with Pearson Chi-Square) indicated a statistically significant association between
gender and the categories, “Yes, within the next 6 months” and “No, not thinking of quitting.”
For these categories, 18 males (47.4%) reported they were not thinking of quitting, whereas 21
females (44.7%) reported they were thinking of quitting within the next 6 months, x² (1, n = 85)
= 6.49, p = 0.04, Cramer’s V = 0.04.
Chi-Square Test for Independence: Differences Between Gender and The Smoking Stage of
Change Questionnaire
Smoking Stage of Change Questionnaire
Are you a current smoker?
Gender

Yes, I currently
smoke

No, I quit within the last 6 months/more than
6 months ago

Male

40 (39.6)

61 (60.4)

Female

47 (44.8)

58 (55.2)

Are you seriously thinking of quitting smoking?
Gender

Yes, within the next
30 days

Yes, within the next 6
months

No, not thinking of
quitting

Male

9 (23.7)

11 (28.9)

18 (47.4)

Female

16 (34)

21 (44.7)

10 (21.3)

Income and The Cigarette Dependence Scale, The Processes of Change Questionnaire, and
The Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a one-way analysis of
variance (ANOVA) was conducted to explore the impact of income on The Cigarette
Dependence Scale, The Smoking Decisional Balance Questionnaire, and The Processes of
Change Questionnaire. For normality of the data, income categories were collapsed to,
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“<$24,000,” “$25,000-$49,999,” and “>$50,000.” There was no significant difference at the p <
0.05 level for The Cigarette Dependence Scale F (2, 72) = 0.15, p = 0.86; The Processes of
Change Questionnaire F (2, 130) = 0.24, p = 0.79; and The Smoking Decisional Balance
Questionnaire F (2, 121) = 0.83, p = 0.44.
ANOVA: Impact of Income on The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
Variable
Df
Sum of
Mean Square
F
p value
Squares
Cigarette
Dependence
Scale

2

20

10

0.15

0.86

Processes of
Change
Questionnaire

2

124.64

62.32

0.24

0.79

Smoking
Decisional
Balance
Questionnaire

2

196.49

98.24

0.83

0.44

Income and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for
independence was used to explore the differences between income and the categories of The
Smoking Stage of Change Questionnaire. When asked, “Are you a current smoker?” the
categories “No, I quit within the last 6 months” and “No, I have never smoked” violated the
minimum cell frequency for chi-square analysis. Subsequently, the category “No, I quit within
the last 6 months” was collapsed with “No, I quit more than 6 months ago,” and “No, I have
never smoked” was excluded from the analysis. Income categories were also collapsed to
<$24,000 and >$25,000 due to violating the minimum cell frequency for chi-square analysis. A
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chi-square test for independence (with Yates’ Continuity Correction) indicated a statistically
significant association between income and the categories, “Yes, I currently smoke” and “No, I
quit within the last 6 months/more than 6 months ago,” x² (1, n = 200) = 6.93, p = 0.01, phi =
0.01.
When asked, “Are you seriously thinking of quitting smoking?” A chi-square test for
independence (with Pearson Chi-Square) indicated no significant association between income
and the categories, “Yes, within the next 30 days,” “Yes, within the next 6 months,” and “No,
not thinking of quitting,” x² (1, n = 85) = 0.94, p = 0.63, Cramer’s V = 0.63.
Chi-Square Test for Independence: Differences Between Income and The Smoking Stage of
Change Questionnaire
Smoking Stage of Change Questionnaire
Are you a current smoker?
Income

Yes, I currently
smoke

No, I quit within the last 6 months/more than
6 months ago

<$24,000

54 (52.4)

49 (47.6)

>$25,000

32 (33)

65 (67)

Are you seriously thinking of quitting smoking?
Income

Yes, within the next
30 days

Yes, within the next 6
months

No, not thinking of
quitting

<$24,000

15 (28.3)

22 (41.5)

16 (30.2)

>$25,000

10 (31.3)

10 (31.3)

12 (37.5)
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Race and The Cigarette Dependence Scale, The Processes of Change Questionnaire, and
The Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, t-tests were conducted to
seek differences in The Cigarette Dependence Scale, The Smoking Decisional Balance
Questionnaire, and The Processes of Change Questionnaire. For The Cigarette Dependence
Scale, there was no significant difference in scores for “White” (M = 43.94, SD = 7.97) and
“Non-White” (M = 41.5, SD = 8.74; t (74) = 0.6, p = 0.55, two tailed). For The Smoking
Decisional Balance Questionnaire, there was no significant difference in scores for “White” (M =
-5.89, SD = 11.08) and “Non-White” (M = -2.71, SD = 5.67 t (122) = -0.75, p = 0.45, two
tailed). For The Processes of Change Questionnaire, there was no significant difference in scores
for “White” (M = 45.88, SD = 16.12) and “Non-White” (M = 44.31, SD = 14.08; t (132) = 0.21,
p = 0.83, two tailed).
T-Test: Differences between Race and The Cigarette Dependence Scale, The Processes of
Change Questionnaire, and The Smoking Decisional Balance Questionnaire
White
Non-white
Variables

Mean

SD

Mean

SD

t

p

Cigarette
Dependence
Scale

43.94

7.97

41.5

8.74

0.6

0.55

Processes of
Change
Questionnaire

45.88

16.12

44.31

14.08

0.21

0.83

Smoking
Decisional
Balance
Questionnaire

-5.89

11.08

-2.71

5.67

-0.75

0.45
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Race and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for
independence was used to explore the differences between race and The Smoking Stage of
Change Questionnaire. Due to the fact that the vast majority of participants were white, the chisquare test for independence was unable to be analyzed without violating the minimum cell
frequency for chi-square analysis.
Comorbid Conditions and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a one-way analysis of
variance (ANOVA) was conducted to explore the impact of comorbid conditions on The
Cigarette Dependence Scale, The Smoking Decisional Balance Questionnaire, and The Processes
of Change Questionnaire. Due to the small number of participants in each chronic condition, the
ANOVA was unable to be analyzed.
Comorbid Conditions and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for
independence was used to explore the differences between comorbid conditions and The
Smoking Stage of Change Questionnaire. Due to the small number of participants in each
chronic condition, the chi-square test for independence was unable to be analyzed without
violating the minimum cell frequency for chi-square analysis.
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Self-Reported Depression and Medication for Depression
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for
independence was used to explore the differences between self-reported depression and
medication for depression. These categories violated the minimum cell frequency for chi-square
analysis; thus, Fisher’s Exact Probability test was reported. For this sample, 108 participants
(98.2%) stated they do not have depression, and do not take medications to treat depression; 2
participants (1.8%) stated they do not have depression but take medications for depression; 25
participants (24.8%) stated they have depression but do not take medications for depression; 76
participants (75.2%) stated they have depression and they take medications for depression. A
chi-square test for independence (with Yates’ Continuity Correction) indicated a statistically
significant association between self-reported depression and medication for depression, x² (1, n =
211) = fisher’s exact test = 0.00.
Chi-Square Test for Independence: Differences Between Self-Reported Depression and
Medication for Depression
Variables
No, I do not take medications
Yes, I take medications
No, I do not have depression

108 (98.2)

2 (1.8)

Yes, I have depression

25 (24.8)

76 (75.2)

Self-Reported Depression and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, t-tests were conducted to
seek differences in The Cigarette Dependence Scale, The Smoking Decisional Balance
Questionnaire, and The Processes of Change Questionnaire based on self-reported depression.
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For The Cigarette Dependence Scale, there was a statistically significant difference in scores for
“Yes, I have depression” (M = 46.03, SD = 7.59) and “No, I do not have depression” (M =
41.56, SD = 7.88; t (72) = 2.49, p = 0.02, two tailed). For the Smoking Decisional Balance
Questionnaire, there was no significant difference in scores for “Yes, I have depression” (M = 5.46, SD = 10.29) and “No, I do not have depression” (M = -6.4, SD = 11.28; t (122) = 0.49, p =
0.63, two tailed). For The Processes of Change Questionnaire, there was a statistically significant
difference in scores for “Yes, I have depression” (M = 49.21, SD = 14.3) and “No, I do not have
depression” (M = 42.75, SD = 17.02; t (131) = 2.36, p = 0.02, two tailed).
T-Test: Differences between Self-Reported Depression and The Cigarette Dependence Scale, The
Processes of Change Questionnaire, and The Smoking Decisional Balance Questionnaire
Yes, I have depression
No, I do not have
depression
Variables

Mean

SD

Mean

SD

t

p

Cigarette
Dependence
Scale

46.03

7.59

41.56

7.88

2.49

0.02

Processes of
Change
Questionnaire

49.21

14.3

42.75

17.02

2.3

0.02

Smoking
Decisional
Balance
Questionnaire

-5.46

10.29

-6.4

11.28

0.49

0.63

Self-Reported Depression and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for
independence was used to explore the differences between self-reported depression and the
categories of The Smoking Stage of Change Questionnaire. When asked, “Are you a current
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smoker?” the categories “No, I quit within the last 6 months” and “No, I have never smoked”
violated the minimum cell frequency for chi-square analysis. Subsequently, the category “No, I
quit within the last 6 months” was collapsed with “No, I quit more than 6 months ago,” and “No,
I have never smoked” was excluded from the analysis. A chi-square test for independence (with
Yates’ Continuity Correction) indicated no significant association between self-reported
depression and the categories, “Yes, I currently smoke” and “No, I quit within the last 6
months/more than 6 months ago,” x² (1, n = 200) = 1.81, p = 0.18, phi = -0.11.
When asked, “Are you seriously thinking of quitting smoking?” A chi-square test for
independence (with Pearson Chi-Square) indicated no significant association between selfreported depression and “Yes, within the next 30 days,” “Yes, within the next 6 months,” and
“No, not thinking of quitting,” x² (1, n = 83) = 1.46, p = 0.48, Cramer’s V = 0.133.
Chi-Square Test for Independence: Differences Between Self-Reported Depression and The
Smoking Stage of Change Questionnaire
Smoking Stage of Change Questionnaire
Are you a current smoker?
Depression

Yes, I currently
Smoke

No, I quit within the last 6 months/more than
6 months ago

No, I do not have
depression

39 (38.5)

65 (62.5)

Yes, I have
depression

46 (47.9)

50 (52.1)

Are you seriously thinking of quitting smoking?
Depression

Yes, within the next
30 days

Yes, within the next 6
months

No, not thinking of
quitting

No, I do not have
depression

13 (34.2)

12 (31.6)

13 (34.2)

Yes, I have
depression

12 (26.7)

20 (44.4)

13 (28.9)
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Medication for Depression and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, t-tests were conducted to
seek differences in The Cigarette Dependence Scale, The Smoking Decisional Balance
Questionnaire, and The Processes of Change Questionnaire based on medication for depression.
For The Cigarette Dependence Scale, there was no significant difference in scores for “Yes, I
take medications to treat depression” (M = 45.82, SD = 7.54) and “No, I do not take medications
to treat depression” (M = 42.23, SD = 8.2; t (71) = 1.93, p = 0.06, two tailed). For The Smoking
Decisional Balance Questionnaire, there was no significant difference in scores for “Yes, I take
medications to treat depression” (M = -5.43, SD = 10.59) and “No, I do not take medications to
treat depression” (M = -6.51, SD = 10.85 t (121) = 0.55, p = 0.59, two tailed). For The Processes
of Change Questionnaire, there was no significant difference in scores for “Yes, I take
medications to treat depression” (M = 48.19, SD = 12.87) and “No, I do not take medications to
treat depression” (M = 44.15, SD = 17.81; t (130.56) = 1.52, p = 0.13, two tailed).
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T-Test: Differences between Medication for Depression and The Cigarette Dependence Scale,
The Processes of Change Questionnaire, and The Smoking Decisional Balance Questionnaire
Yes, I take medications
No, I do not take
medications
Variables

Mean

SD

Mean

SD

t

p

Cigarette
Dependence
Scale

45.82

7.54

42.23

8.2

1.93

0.06

Processes of
Change
Questionnaire

48.19

12.87

44.15

17.81

1.52

0.13

Smoking
Decisional
Balance
Questionnaire

-5.43

10.59

-6.51

10.85

0.55

0.59

Medication for Depression and The Smoking Stage of Change Questionnaire
To describe the characteristics of a convenience sample of people living with COPD and
differing categories of depression who sought care in West Virginia, a chi-square test for
independence was used to explore the differences between medication for depression and the
categories of The Smoking Stage of Change Questionnaire. When asked, “Are you a current
smoker?” the categories “No, I quit within the last 6 months” and “No, I have never smoked”
violated the minimum cell frequency for chi-square analysis. Subsequently, the category “No, I
quit within the last 6 months” was collapsed with “No, I quit more than 6 months ago,” and “No,
I have never smoked” was excluded from the analysis. A chi-square test for independence (with
Yates’ Continuity Correction) indicated a statistically significant association between medication
for depression and the categories, “Yes, I currently smoke” and “No, I quit within the last 6
months/more than 6 months ago,” x² (1, n = 199) = 5.39, p = 0.02, phi = 0.01.
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When asked, “Are you seriously thinking of quitting smoking?” A chi-square test for

independence (with Pearson Chi-Square) indicated no significant association between
medication for depression and “Yes, within the next 30 days,” “Yes, within the next 6 months,”
and “No, not thinking of quitting,” x² (1, n = 82) = 0.97, p = 0.62, Cramer’s V = 0.62.
Chi-Square Test for Independence: Differences Between Medication for Depression and The
Smoking Stage of Change Questionnaire
Smoking Stage of Change Questionnaire
Are you a current smoker?
Medications

Yes, I currently
Smoke

No, I quit within the last 6 months/more than
6 months ago

No, I do not take
medications

44 (35.5)

80 (64.5)

Yes, I take
medications

40 (53.3)

35 (46.7)

Are you seriously thinking of quitting smoking?
Medications

Yes, within the next
30 days

Yes, within the next 6
months

No, not thinking of
quitting

No, I do not take
medications

15 (34.9)

15 (34.9)

13 (30.2)

Yes, I take
medications

10 (25.6)

17 (43.6)

12 (30.8)
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Aim 2: To Describe the Differences Between People with COPD and Differing Categories
of Depression (Minimal, Mild, Moderate, Moderately Severe, Severe, or No Depression)
Related to Smoking Behaviors and Readiness to Change
Depression Severity and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
To describe the differences between people with COPD and differing categories of
depression (minimal, mild, moderate, moderately severe, severe, or no depression) related to
smoking behaviors and readiness to change, an ANOVA was used to compare the means of The
Cigarette Dependence Scale, The Processes of Change Questionnaire, and The Smoking
Decisional Balance Questionnaire. For normality of the data, depression categories were
collapsed to “none/minimal depression,” “mild/moderate depression,” and “moderately
severe/severe depression.” There was no significant difference at the p < 0.05 level for The
Cigarette Dependence Scale F (2, 66) = 2.7, p = 0.08 and The Processes of Change
Questionnaire F (2, 123) = 2.88, p = 0.06. There was a statistically significant difference at the p
< 0.05 for The Smoking Decisional Balance Questionnaire F (2, 112) = 5.3, p = 0.01, where
those with mild and moderate depression saw more cons to smoking in comparison to those with
none/minimal depression and moderately severe/severe depression.
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ANOVA: Depression Severity and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
Variable
Df
Sum of
Mean Square
F
p value
Squares
Cigarette
Dependence
Scale

2

332.25

166.13

2.7

0.08

Processes of
Change
Questionnaire

2

1441.11

720.56

2.88

0.06

Smoking
Decisional
Balance
Questionnaire

2

1137.54

568.77

5.3

0.01

Depression Severity and The Smoking Stage of Change Questionnaire
To describe the differences between people with COPD and differing categories of
depression (minimal, mild, moderate, moderately severe, severe, or no depression) related to
smoking behaviors and readiness to change, a chi-square test for independence was used to
compare the differences between The Smoking Stage of Change Questionnaire and the PHQ-9
results. Due to the small number of participants that did not have depression, the chi-square test
for independence was unable to be analyzed without violating the minimum cell frequency for
chi-square analysis.
Aim 3: To Explore the Relationships among COPD, Depression, Smoking Behaviors, and
Readiness to Change
Sub-Aim 3a: To Describe the Relationships among COPD, Depression, and The Cigarette
Dependence Scale.
To describe the relationships among COPD, depression, and The Cigarette Dependence
Scale, Pearson correlation was used with the PHQ-9 results. Preliminary analyses were
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performed to ensure no violation of the assumptions of normality, linearity, and
homoscedasticity. There was a statistically significant medium, positive correlation between the
two variables, r = 0.32, n = 74, p = 0.01, with high levels of cigarette dependence associated with
more severe depression.
Sub-Aim 3b: To Describe the Relationships among COPD, Depression, and The Smoking
Decisional Balance Questionnaire.
To describe the relationships among COPD, depression, and The Smoking Decisional
Balance Questionnaire, Pearson correlation was used with the PHQ-9 results. Preliminary
analyses were performed to ensure no violation of the assumptions of normality, linearity, and
homoscedasticity. There was a small, non-significant negative correlation between the two
variables, r = -0.02, n = 121, p = 0.85, with high levels of depression associated with the patient
endorsing more cons for smoking.
Sub-Aim 3c: To Describe the Relationships among COPD, Depression, and The Processes
of Change Questionnaire
To describe the relationships among COPD, depression, and The Processes of Change
Questionnaire, Pearson correlation was used with the PHQ-9 results. Preliminary analyses were
performed to ensure no violation of the assumptions of normality, linearity, and
homoscedasticity. There was a statistically significant small, positive correlation between the
two variables, r = 0.26, n = 132, p = 0.00, with high use of the processes of change associated
with more severe depression.
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Pearson Correlation: PHQ-9 and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, and The Smoking Decisional Balance Questionnaire
Variable
Cigarette Dependence Processes of Change Smoking Decisional
Scale
Questionnaire
Balance
Questionnaire
PHQ-9

0.32, p = 0.01

0.26, p = 0.00

-0.02, p = 0.85

Aim 4: To Analyze the Relationships among COPD, Depression, Smoking Behaviors, and
Readiness to Change
COPD, Depression Severity, and The Cigarette Dependence Scale
To analyze the relationships among COPD, depression, smoking behaviors, and readiness
to change, a linear regression was used to assess the ability of one control measure (depression
severity) to predict cigarette dependence (The Cigarette Dependence Scale). Preliminary
analyses were conducted to ensure no violation of the assumptions of normality, linearity,
multicollinearity, and homoscedasticity. The total variance explained by the model was 9%, F (1,
72) = 8.18, p < 0.01.
COPD, Depression Severity, and The Processes of Change Questionnaire
To analyze the relationships among COPD, depression, smoking behaviors, and readiness
to change, a linear regression was used to assess the ability of one control measure (depression
severity) to predict processes of change (The Processes of Change Questionnaire). Preliminary
analyses were conducted to ensure no violation of the assumptions of normality, linearity,
multicollinearity, and homoscedasticity. The total variance explained by the model was 5.9%, F
(1, 130) = 9.19, p < 0.00.
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COPD, Depression Severity, and The Cigarette Dependence Scale- Controlling for SelfReported Depression
To analyze the relationships among COPD, depression, smoking behaviors, and readiness
to change, multiple linear regression was used to assess the ability of one control measure (PHQ9) to predict cigarette dependence (The Cigarette Dependence Scale), after controlling for selfreported depression. Preliminary analyses were conducted to ensure no violation of the
assumptions of normality, linearity, multicollinearity, and homoscedasticity. Self-reported
depression explained 10% of the variance in cigarette dependence. No control measures were
statistically significant, with self-reported depression recording a higher beta value (beta = 2.94,
p = 0.17) than PHQ-9 (beta = 0.27, p = 0.09).
Multiple Linear Regression: COPD, Depression Severity, and The Cigarette Dependence ScaleControlling for Self-Reported Depression
Variable
B
SE
95% CI
P
PHQ-9

0.27

0.16

-0.05-0.58

0.09

Self-reported
depression

2.94

2.12

-1.28-7.16

0.17

COPD, Depression Severity, and The Processes of Change Questionnaire- Controlling for
Self-Reported Depression, Gender, and Age
To analyze the relationships among COPD, depression, smoking behaviors, and readiness
to change, multiple linear regression was used to assess the ability of one control measure (PHQ9) to predict processes of change (The Processes of Change Questionnaire), after controlling for
self-reported depression. Preliminary analyses were conducted to ensure no violation of the
assumptions of normality, linearity, multicollinearity, and homoscedasticity. Self-reported
depression explained 6.3% of the variance in processes of change. No control measures were
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statistically significant, with self-reported depression recording a higher beta value (beta = 3.95,
p = 0.25) than PHQ-9 (beta = 0.47, p = 0.08).
Multiple Linear Regression: COPD, Depression Severity, and The Processes of Change
Questionnaire - Controlling for Self-Reported Depression
Variable
B
SE
95% CI
P
PHQ-9

0.47

0.26

-0.06-0.99

0.08

Self-reported
depression

3.95

3.4

-2.79-10.68

0.25

To analyze the relationships among COPD, depression, smoking behaviors, and readiness
to change, multiple linear regression was used to assess the ability of one control measure (PHQ9) to predict processes of change (The Processes of Change Questionnaire), after controlling for
gender. Preliminary analyses were conducted to ensure no violation of the assumptions of
normality, linearity, multicollinearity, and homoscedasticity. Gender explained 12% of the
variance in processes of change. Two control measures were statistically significant, with gender
recording a higher beta value (beta = 8.32, p = 0.00) than PHQ-9 (beta = 0.5, p = 0.02).
Multiple Linear Regression: COPD, Depression Severity, and The Processes of Change
Questionnaire - Controlling for Gender
Variable
B
SE
95% CI
P
PHQ-9

0.5

0.21

0.08-0.9

0.02

Gender

8.32

2.67

3.03-13.6

0.00

To analyze the relationships among COPD, depression, smoking behaviors, and readiness
to change, multiple linear regression was used to assess the ability of one control measure (PHQ9) to predict processes of change (The Processes of Change Questionnaire), after controlling for
age. Preliminary analyses were conducted to ensure no violation of the assumptions of normality,
linearity, multicollinearity, and homoscedasticity. Age explained 7.1% of the variance in
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processes of change. One control measure was statistically significant, with the PHQ-9 recording
a higher beta value (beta = 0.51, p = 0.03) than age (beta = -0.24, p = 0.11).
Multiple Linear Regression: COPD, Depression Severity, and The Processes of Change
Questionnaire - Controlling for Age
Variable
B
SE
95% CI
P
PHQ-9

0.51

0.23

0.06-0.95

0.03

Age

-0.24

0.15

-0.53-0.05

0.11
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Chapter Five: Findings
Aim 1: To Describe the Characteristics of a Convenience Sample of People Living with
COPD and Differing Categories of Depression who sought care in West Virginia
Descriptive Statistics on Participant Characteristics
The characteristics of a convenience sample of people living with COPD and differing
categories of depression who sought care in West Virginia aligned with the demographics of the
state. The findings related to gender, race, age, and income support the hypothesis that the
demographic data from this study would be similar to a sample of COPD patients from West
Virginia. In the state, females have a higher prevalence of COPD at 16.6%, in comparison to
males at 14% (American Lung Association, 2020). In West Virginia, 93.6% of the population is
white, and COPD is found to be prevalent in West Virginia residents ages 55-64, who have an
income of less than $15,000 (West Virginia Department of Health and Human Resources, 2021).
The findings related to education in this study are characteristic of West Virginia
residents. The vast majority of residents graduate from high school (86.9%), and few residents
receive a college education (20.6%) (United States Census Bureau, 2019). The prevalence of
diabetes and congestive heart failure in the sample aligned with the prevalence of these diseases
in the state. West Virginia ranks first in the nation for cardiovascular disease and second in the
nation for diabetes (West Virginia Department of Health and Human Resources, 2021). The
percentage of adults that report depression in West Virginia is 28.8% (United Health Foundation,
2021). In comparison to the findings of this study, this indicates that the prevalence of depression
is higher among a sample of patients with COPD (45.5%). These findings help identify
sociodemographic factors that are characteristic for patients with comorbid COPD and
depression who seek care in West Virginia.
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The hypothesis that the demographic data from this study would be different from
demographic data from a national sample of COPD patients was rejected. It is known that COPD
is more prevalent in individuals that have a lower income, and psychological distress is reported
in 42.8% of COPD patients (American Lung Association, 2020). In a national sample of patients
that self-reported COPD, the majority of participants were white women, 65 years and older;
were of low income; and attended one year or more of college (Floyd et al., 2018). These
characteristics are similar to those with COPD and depression who sought care in West Virginia.
Understanding these sociodemographic factors, such as education level, the presence of multiple
chronic conditions, and high rates of depression, are important in clinical practice for the
successful management of patients with COPD, especially those with comorbid depression.
Descriptive Statistics on the PHQ-9, Self-Reported Depression, and Medication for
Depression
To describe the depression severity of this sample, the responses to the PHQ-9 were
analyzed. The mean (7.9) indicated participants suffered from mild depression; however,
differing categories of depression existed among the sample. Despite the 113 participants
(50.9%) who self-reported that they did not have depression, the PHQ-9 results showed that only
18 participants (8.1%) were classified as having no depression. In the COPD population,
depression often goes undiagnosed and is missed in approximately 50% of patients (Yohannes et
al., 2011). In this sample, it can be said that depression was under-diagnosed in 38.8% of the
participants. This finding highlights the need for continual depression screening in clinical
practice using validated clinical screening tools for individuals living with COPD.
To describe the characteristics of the sample, medication use for depression was
analyzed. Differing categories of depression require variability in treatment. When the PHQ-9 is
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used in clinical practice, pharmacotherapy is a proposed treatment option when a patient scores a
severity of depression as moderate or greater (Patient-Centered Primary Care Collaborative,
2019). In this population, 34.3 % could benefit from pharmacotherapy, which aligned with the
participants’ self-reported medication use (35.6%). However, it is clear from these results that
even those taking medication were still showing some level of depressive symptoms. It is
estimated that 40% of patients diagnosed with depression receive adequate treatment, which
accurately describes the population of this study (Yohannes et al., 2011). This finding highlights
the need to verify medication adherence, assess medication effectiveness, and assess the need for
adjunct treatment interventions for depression.
Descriptive Statistics on The Cigarette Dependence Scale, The Processes of Change
Questionnaire, The Processes of Change Questionnaire Sub-Scales, The Smoking
Decisional Balance Questionnaire, and The Smoking Stage of Change Questionnaire.
Descriptive statistics were used to describe the total sample in relation to smoking
behaviors, as measured by The Cigarette Dependence Scale. Unsurprisingly, participants who
smoked reported high levels of nicotine dependence. This finding is typical of the COPD
population (Jiménez Ruiz et al., 2012). This finding is also typical of those with a psychological
and behavioral health diagnosis (Steinberg et al., 2015). Psychological and behavioral health
diagnoses, such as depression impact nicotine dependence. Patients that have depression are
known to smoke more cigarettes and have higher nicotine dependence than those who do not
have depression (Michal et al., 2013). This highlights the need for policies related to adequate
smoking cessation tools in West Virginia, specifically for those with comorbid COPD and
depression.
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Descriptive statistics were used to describe the total sample in relation to their readiness
to change, as measured by The Smoking Stage of Change Questionnaire. The findings of this
analysis are supported in the literature showing that one third of COPD patients continue to
smoke (39.2%) (Hilberink et al., 2005). In this sample, only 12.6% of smoking participants
indicated they were not thinking of quitting. Most participants wanted to quit within the next 30
days or within the next 6 months (25.7%). This is consistent with the belief that half of adult
smokers desire to achieve cessation (Centers for Disease Control and Prevention, 2017). Patients
who receive smoking cessation advice from a clinician are more likely to achieve cessation
(Prochaska et al., 2017). Knowing that most COPD patients in this sample are thinking of
quitting highlights the importance of assessing patients for their readiness to change in clinical
practice.
The Smoking Stage of Change Questionnaire results also classified participants into their
perceived stage of change. These findings support the assumption that most current smokers are
not ready to act (Prochaska & Velicer, 1997). Therefore, action-oriented smoking cessation
programs are not conducive for this population. Interventions and policies aimed at increasing
readiness to change are needed, especially in this population. Since most smoking cessation
programs in West Virginia are action-oriented, this finding highlights the need for policy
changes regarding reimbursement of smoking cessation programs that increase readiness to
change in the state.
Descriptive statistics were used to describe the total sample in relation to their readiness
to change, as measured by The Smoking Decisional Balance Questionnaire. These findings
indicated that the sample saw more negative aspects to smoking then positives. Participants
perceptions on the pros and cons of smoking are important to evaluate, as they can vary
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depending on the stage of change. In this population, a large portion of current smokers were
classified as being in the contemplation stage. In this stage, individuals reflect on the positive
and negative aspects of changing their behavior. Individuals can dwell in this stage, which is
referred to as chronic contemplation. To prevent chronic contemplation, individuals’ readiness to
change must be evaluated so personalized interventions can be implemented to promote change.
The total sample was analyzed for readiness to change, as measured by The Processes of
Change Questionnaire. These findings indicated that the population was engaged in various
processes of change. Identifying situations and thoughts that help participants progress through
the stages of change are important to develop individualized interventions (Prochaska & Velicer,
1997). For this sample, participants used more experiential processes (23.65) than behavioral
processes (20.4). This means that experiential activities were used more often than behavior
activities to progress through the stages of change. Social liberation was the most used process of
change (4.72). Social liberation refers to when individuals experience more alternatives or social
opportunities (Prochaska & Velicer, 1997). New opportunities and new policies that promote
health are imperative to help participants move through the stages of change. This highlights the
need for advocacy for health promotion opportunities and alternatives.
Consciousness raising was the second most used process of change (4.3). Consciousness
raising refers to when individuals recognize the health behavior and acknowledge the
consequences (Prochaska & Velicer, 1997). These findings align with those of The Smoking
Decisional Balance Questionnaire. Participants endorsed more negative aspects to smoking then
positives. Participants of this study clearly recognized the health behavior, acknowledged the
consequences, and continued to smoke. Hence, identifying factors that influence the decision to
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not smoke may need to be assessed along with education regarding the dangers of smoking
(Prochaska & Velicer, 1997).
Stimulus control, which is a behavioral process, was the least used process of change
(2.56) among the sample. Stimulus control refers to when individuals remove unhealthy behavior
cues and replace them with prompts for healthy behavior (Prochaska & Velicer, 1997). This
behavioral process is used most often during the action stage (Prochaska & DiClemente, 1983).
With few participants (1.8%) in the action stage, this supports the belief that certain processes of
change are only used during specific stages of change. Future research should be aimed at
interventions that target smoking cessation specific for participants’ stage of change while
considering the other unique characteristics of this population, such as, gender, income, race,
education, comorbid conditions, depression severity, medication use, smoking decisional
balance, processes of change, and smoking behaviors.
Aim 2: To Describe the Differences Between People with COPD and Differing Categories
of Depression (Minimal, Mild, Moderate, Moderately Severe, Severe, or No Depression)
Related to Smoking Behaviors and Readiness to Change
Depression Severity and The Cigarette Dependence Scale, The Processes of Change
Questionnaire, The Smoking Decisional Balance Questionnaire, and The Smoking Stage of
Change Questionnaire
There was no difference between people who had COPD and differing categories of
depression related to smoking behaviors, as measured by The Cigarette Dependence Scale (p =
0.08). This was a new finding as psychological and behavioral health diagnoses are associated
with higher levels of nicotine dependence (Steinberg et al., 2015). This finding rejects the
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hypothesis that participants with increased levels of depression would have a higher level of
cigarette dependence.
There was no difference between people who had COPD and differing categories of
depression related to readiness to change, as measured by The Processes of Change
Questionnaire (p = 0.06). There was a statistically significant difference at the p < 0.05 for
people who had COPD and differing categories of depression related to readiness to change, as
measured by The Smoking Decisional Balance Questionnaire. Depression severity does affect
how one perceives the pros and cons of smoking. Depression causes mood irregularities, which
have been identified as a barrier to cessation for patients with psychological and behavioral
health diagnoses (El-Mallakh et al., 2016). This highlights the importance of adequate depression
treatment for this population.
Differences between people who had COPD only and those who had COPD and
depression related to readiness to change, as measured by The Smoking Stage of Change
Questionnaire, were unable to be analyzed. The data was unable to be analyzed without violating
the minimum cell frequency for chi-square analysis. Hypotheses related to the stages of change
were unable to be evaluated. Future research should be powered adequately to address this
limitation.
Differing categories of depression does impact patients’ readiness to change. For COPD
patients that continue to smoke, continual assessment of individuals’ severity of depression is of
the utmost importance. Adequate treatment of depression could improve smoking cessation rates
in this population.
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Aim 3: To Explore the Relationships among COPD, Depression, Smoking Behaviors, and
Readiness to Change
Sub-Aim 3a: To Describe the Relationships among COPD, Depression, and The Cigarette
Dependence Scale
The relationship among COPD, depression, and smoking behaviors, as measured by The
Cigarette Dependence Scale, indicated that a statistically significant medium, positive correlation
exists. This finding supports the hypothesis that participants with higher depression severity
would report a higher level of cigarette dependence. This finding is supported in the literature. It
is well known that the prevalence of smoking is higher for those that have depression (ElMallakh et al., 2016). Those that have a psychological and behavioral health diagnoses are less
likely to achieve cessation than the general population (Burns et al., 2017). A dose-response
relationship between smoking and mood disorders exists (Goodwin et al., 2012) Understanding
the smoking behaviors of this population is important, as smoking behaviors impact disease
management and outcomes. Depression and nicotine dependence could be factors that are
impacting smoking cessation in this population.
Sub-Aim 3b: To Describe the Relationships among COPD, Depression, and The Smoking
Decisional Balance Questionnaire
The relationship among COPD, depression, and readiness to change, as measured by The
Smoking Decisional Balance Questionnaire, indicated that a small, negative correlation exists
with high levels of depression associated with the patient endorsing more cons for smoking. This
finding rejects the hypothesis that participants with higher depression severity would report more
pros for smoking than cons for smoking. It is apparent that participants of this study understood
smoking and the negative affects smoking has on health. There may be a reciprocal relationship
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between the variables. Depression may lead to increased smoking behavior, which leads to
worsening COPD and could lead to increased depression and more smoking. All of this may
decrease the ability or desire to quit. Interventions aimed at treating depression instead of solely
on smoking cessation seem to be warranted. Future research should examine rates of smoking
cessation when depression is controlled prior to cessation interventions.
Sub-Aim 3c: To Describe the Relationships among COPD, Depression, and The Processes
of Change Questionnaire
The relationship among COPD, depression, and readiness to change, as measured by The
Processes of Change Questionnaire indicated that a statistically significant small, positive
correlation exists, with high use of the processes of change associated with more severe
depression. This rejects the hypothesis that participants with higher depression severity would
not report use of processes of change. Participants with higher depression severity want to quit
and want to progress through the stages of change. The Transtheoretical Model approach to
behavior change enhances self-control, which is important for those with depression (Prochaska
& Velicer, 1997). There is a need for personalized interventions to target the stage and promote
change for this population. Focusing on depression control may be the key to assisting patients
through the stages of change and ultimately improving cessation rates and COPD outcomes.
Aim 4: To Analyze the Relationships among COPD, Depression, Smoking Behaviors and
Readiness to Change
COPD, Depression Severity, and The Cigarette Dependence Scale
Further analysis was done to analyze the statistically significant medium, positive
correlation among COPD, depression, and smoking behaviors, as measured by The Cigarette
Dependence Scale. This was the first study to examine the relationship among these variables
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with a sample of participants who sought care in West Virginia. Linear regression results showed
that if depression is treated, cigarette dependence could decrease for 9% of COPD patients. This
emphasizes the importance of screening and treating patients with COPD for depression in
clinical practice.
COPD, Depression Severity, and The Processes of Change Questionnaire
Further analysis was done to analyze the statistically significant small, positive
correlation among COPD, depression, and readiness to change, as measured by The Processes of
Change Questionnaire. Depression severity explained 5.9% of the variance in the population’s
engagement in the processes of change. Given the possible reciprocal relationship between the
variables, this finding could illustrate how participants experience chronic contemplation.
Participants want to use the processes of change to progress through the stages of change;
however, depression interferes with their progression. Future research should assess and treat
COPD patients for depression and measure how this intervention affects patients smoking
behaviors and readiness to change.
COPD, Depression Severity, and The Cigarette Dependence Scale- Controlling for SelfReported Depression
Further analysis was done to analyze the relationships among COPD, depression, and
smoking behaviors, as measured by The Cigarette Dependence Scale, controlling for selfreported depression. This supports the hypothesis that there would be at least one statistically
significant covariate identified for a dependent variable. Self-reported depression explained 10%
of the variance in cigarette dependence. However, this finding is not statistically significant.
Given the PHQ-9 results, many participants did not know they had depression. Therefore, the
self-reported depression findings were inaccurate. This emphasizes the need to use validated
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depression screening tools for individuals living with COPD. Future research should compare
documented depression diagnoses with patients PHQ-9 results.
COPD, Depression Severity, and The Processes of Change Questionnaire- Controlling for
Gender, Age, and Self-Reported Depression
Further analysis was done to analyze the relationships among COPD, depression, and
readiness to change, as measured by The Processes of Change Questionnaire, controlling for the
variables, gender, age, and self-reported depression. This supports the hypothesis that there
would be at least one statistically significant covariate identified for a dependent variable. Age
explained 7.1% of the variance in the population’s engagement in the processes of change.
Gender explained 12% of the variance in the population’s engagement in the processes of
change. Self-reported depression explained 6.3% of the variance in the population’s engagement
in the processes of change. Age and gender are not modifiable variables. However, depression
severity can be modified. Knowing that the self-reported depression variable may not be
adequately capturing true depression status, future research should be aimed at adequately
assessing, diagnosing, and treating depression to determine impact on outcomes, specifically
related to the processes of change.
Limitations
Limitations of the study included the descriptive cross-sectional design. Data was
collected from February 2020 to November 2020. A true cause and effect relationship cannot be
determined with this study design (Polit & Beck, 2017).
Sampling was a limitation of this study. This study used a convenience sample to recruit
participants, which is prone to sampling bias (Polit & Beck, 2017). For inclusion in the study,
participants self-reported a diagnosis of COPD, self-reported being able to read English at a 6th
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grade level, and self-reported being a current or former smoker. During face-to-face recruitment
at the Pulmonary Clinic, the provider verified participants’ COPD diagnosis and smoking status.
During other recruitment strategies, COPD diagnosis, reading level, and smoking status were not
otherwise validated.
For recruitment mailings, patients that had a diagnosis of COPD in their electronic
medical record received mailings. COPD is often used as an umbrella term for chronic
respiratory diseases. It is possible patients had COPD listed in their electronic medical record
without having pulmonary function tests to support the diagnosis. All of these factors could lead
to a misrepresented sample. Generalizability of the results to West Virginia is limited, as being a
West Virginia resident was not in the inclusion criteria for this study. Generalizability of the
results to other geographical locations is limited due to the racial homogeneity of the sample.
There is no formal psychometric data to support The Smoking Stage of Change
Questionnaire. A total processes of change score was used for data analysis. This score gives
information regarding participants’ overall engagement in various processes of change. It does
not analyze the specific processes of change being used. Further analysis utilizing the processes
of change sub-scales would be beneficial for future research.
Despite over sampling, the study was not adequately powered for all statistical analyses.
Data that was received by a mailed survey was entered into RedCap by the researcher. Errors in
data input may have occurred during this process. Data was also collected during the COVID-19
pandemic. For the COPD population, depression severity may have been impacted by the
pandemic and the social isolation experienced during quarantine.

82
Conclusion
Patients with comorbid COPD and depression require variability in treatment. Successful
management of these patients includes understanding their sociodemographic factors, depression
severity, smoking behaviors, and readiness to change. COPD patients need to receive continual
screening and treatment for depression. Treatment for depression can improve COPD patient
outcomes and aid in achieving smoking cessation. For current smokers, smoking behaviors need
to be assessed to understand patients’ current level of depression, smoking status, frequency of
use, and nicotine dependence. To achieve cessation, the relationship between depression and
readiness to change needs to be assessed to develop personalized smoking cessation
interventions. Practitioners must understand patients perceived stage, pros and cons, and
situations and thoughts that occur in the process of change to help achieve cessation. The
relationships among smoking, COPD, and depression must be recognized to address the complex
health care needs of this population. Future research should be aimed at understanding the
specific link between depression and readiness to change.

83
References
Alexopoulos, Kiosses, D. N., Sirey, J. A., Kanellopoulos, D., Seirup, J. K., Novitch, R. S., . . .
Raue, P. J. (2014). Untangling therapeutic ingredients of a personalized intervention for
patients with depression and severe COPD. The American Journal of Geriatric
Psychiatry, 22(11), 1316-1324. doi:10.1016/j.jagp.2013.05.006
Alexopoulos, G., Sirey, J., Banerjee, S., Kiosses, D., Pollari, C., Novitch, R., . . . Raue, P.
(2016). Two behavioral interventions for patients with major depression and severe
COPD. The American Journal of Geriatric Psychiatry, 24(11), 964-974.
doi:10.1016/j.jagp.2016.07.014
American Cancer Society Cancer Action Network. (2017). How do you measure up. Retrieved
from https://www.acscan.org/sites/default/files/National%20Documents/HDYMU2017.pdf#page=13
American Lung Association. (2017). How serious is COPD. Retrieved from
http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/learn-aboutcopd/how-serious-is-copd.html
American Lung Association. (2020). COPD Trends Brief Retrieved from
https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief
Appalachian Regional Commission. (2017). Health Disparities in Appalachia Retrieved from
https://www.arc.gov/assets/research_reports/Health_Disparities_in_Appalachia_August_
2017.pdf
Beauchamp, T. (2008). The Belmont Report. In Oxford Textbook of Clinical Research Ethics.
Bjarnason, N. H., Mikkelsen, K. L., & Tønnesen, P. (2010). Smoking habits and beliefs about
smoking in elderly patients with COPD during hospitalization. Journal of Smoking
Cessation, 5(1), 15-21. doi:10.1375/jsc.5.1.15
Bratek, A., Zawada, K., Beil-Gawełczyk, J., Beil, S., Sozańska, E., Krysta, K., . . . Pierzchała,
W. (2015). Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients
with asthma and chronic obstructive pulmonary disease (COPD): Possible associations
with inflammation markers: A pilot study. Journal of Neural Transmission, 122(Suppl 1),
83-91. doi:10.1007/s00702-014-1171-9
Burns, A., Strawbridge, J. D., Clancy, L., & Doyle, F. (2017). Exploring smoking, mental health
and smoking-related disease in a nationally representative sample of older adults in
Ireland - A retrospective secondary analysis. Journal of Psychosomatic Research, 98, 7886. doi:10.1016/j.jpsychores.2017.05.005
Centers for Disease Control and Prevention. (2017). Quitting Smoking. Retrieved from
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm
Centers for Disease Control and Prevention. (2018). Health Effects of Cigarette Smoking
Retrieved from
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoki
ng/index.htm
Centers for Disease Control and Prevention. (2019a). Current Cigarette Smoking Among Adults
in the United States. Retrieved from
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.ht
m

84
Centers for Disease Control and Prevention. (2019b). Economic Trends in Tobacco Retrieved
from
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/economics/econ_facts/index.htm
Christenhusz, Pieterse, M., Seydel, E., & van der Palen, J. (2007). Prospective determinants of
smoking cessation in COPD patients within a high intensity or a brief counseling
intervention. Patient Education and Counseling, 66(2), 162-166.
doi:10.1016/j.pec.2006.11.006
Christenhusz, Prenger, R., Pieterse, M. E., Seydel, E. R., & van der Palen, J. (2012). Costeffectiveness of an intensive smoking cessation intervention for COPD outpatients.
Nicotine & Tobacco Research, 14(6), 657-663. doi:10.1093/ntr/ntr263
DiClemente, C. C., & Prochaska, J. O. (1982). Self-change and therapy change of smoking
behavior: a comparison of processes of change in cessation and maintenance. Addictive
behaviors, 7(2), 133-142.
Division of Tobacco Prevention. (2018). West Virginia Tobacco Quitline. Retrieved from
http://dhhr.wv.gov/wvdtp/cessation/Quitline/Pages/default.aspx
El-Mallakh, P., McPeak, D., Khara, M., & Okoli, C. T. (2016). Smoking Behaviors and Medical
Co-Morbidities in Patients With Mental Illnesses. Archives of psychiatric nursing, 30(6),
740-746. doi:10.1016/j.apnu.2016.07.003
Emanuel, E., Wendler, D., & Grady, C. (2008). An Ethical Framework for biomedical resaerch.
In the Oxford Textbook of Clinical Research Ethics.
Etter, J.-F. o., Le Houezec, J., & Perneger, T. V. (2003). A self-administered questionnaire to
measure dependence on cigarettes: The cigarette dependence scale.
Neuropsychopharmacology, 28(2), 359-370.
Floyd, J., Mallow, J., & Theeke, L. (2018). Health-related quality of life, depression, and
smoking status in patients with COPD: Results from the 2016 Behavioral Risk Factor
Surveillance System data Open Journal of Nursing 8, 779-794.
Goodwin, R. D., Lavoie, K. L., Lemeshow, A. R., Jenkins, E., Brown, E. S., & Fedoronko, D. A.
(2012). Depression, anxiety, and COPD: The unexamined role of nicotine dependence.
Nicotine & Tobacco Research, 14(2), 176-183. doi:10.1093/ntr/ntr165
Hilberink, S. R., Jacobs, J. E., Bottema, B. J. A. M., de Vries, H., & Grol, R. P. T. M. (2005).
Smoking cessation in patients with COPD in daily general practice (SMOCC): Six
months' results. Preventive Medicine: An International Journal Devoted to Practice and
Theory, 41(5-6), 822-827. doi:10.1016/j.ypmed.2005.08.003
Himelhoch, S., Riddle, J., & Goldman, H. H. (2014). Barriers to implementing evidence-based
smoking cessation practices in nine community mental health sites. Psychiatric services
(Washington, D.C.), 65(1), 75-80. doi:10.1176/appi.ps.201200247
Ho, S. Y., Alnashri, N., Rohde, D., Murphy, P., & Doyle, F. (2015). Systematic review and
meta-analysis of the impact of depression on subsequent smoking cessation in patients
with chronic respiratory conditions. General Hospital Psychiatry, 37(5), 399-407.
doi:10.1016/j.genhosppsych.2015.05.002
Japuntich, S. J., Sherman, S. E., Joseph, A. M., Clothier, B., Noorbaloochi, S., Danan, E., . . . Fu,
S. S. (2018). Proactive tobacco treatment for individuals with and without a mental health
diagnosis: Secondary analysis of a pragmatic randomized controlled trial. Addictive
behaviors, 76, 15-19. doi:10.1016/j.addbeh.2017.07.024
Jiménez Ruiz, C. A., Pinedo, A. R., Guerrero, A. C., Uibarri, M. M., Fernández, M. C., &
Gonzalez, G. L. (2012). Characteristics of COPD smokers and effectiveness and safety of

85
smoking cessation medications. Nicotine & Tobacco Research, 14(9), 1035-1039.
doi:10.1093/ntr/nts001
Jonsdottir, H., Amundadottir, O. R., Gudmundsson, G., Halldorsdottir, B. S., Hrafnkelsson, B.,
Ingadottir, T. S., . . . Stefansdottir, I. K. (2015). Effectiveness of a partnership-based selfmanagement programme for patients with mild and moderate chronic obstructive
pulmonary disease: A pragmatic randomized controlled trial. Journal of Advanced
Nursing, 71(11), 2634-2649. doi:10.1111/jan.12728
King, J. L., Reboussin, B. A., Spangler, J., Cornacchione Ross, J., & Sutfin, E. L. (2018).
Tobacco product use and mental health status among young adults. Addictive behaviors,
77, 67-72. doi:10.1016/j.addbeh.2017.09.012
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9 : Validity of a brief
depression severity measure. Journal of General Internal Medicine, 16(9), 606-613.
doi:10.1046/j.1525-1497.2001.016009606.x
Lawrence, D., Hafekost, J., Hull, P., Mitrou, F., & Zubrick, S. R. (2013). Smoking, mental
illness and socioeconomic disadvantage: analysis of the Australian National Survey of
Mental Health and Wellbeing. BMC Public Health, 13(1), 1-20. doi:10.1186/1471-245813-462
Lee, J., Park, J., Kim, H., & Shin, H. (2014). Smoking behaviors among people with disabilities
in Korea. Disability and Health Journal, 7(2), 236-241. doi:10.1016/j.dhjo.2013.11.002
Lou, P., Chen, P., Zhang, P., Yu, J., Wang, Y., Chen, N., . . . Zhao, J. (2014). Effects of smoking,
depression, and anxiety on mortality in COPD patients: a prospective study. Respiratory
care, 59(1), 54-61. doi:10.4187/respcare.02487
Matte, D., Pizzichini, M., Hoepers, A., Diaz, A., Karloh, M., Dias, M., & Pizzichini, E. (2016).
Prevalence of depression in COPD: A systematic review and meta-analysis of controlled
studies. Respiratory Medicine, 117, 154-161. doi:10.1016/j.rmed.2016.06.006
Mental Health Foundation. (2019). Smoking and Mental Health Retrieved from
https://www.mentalhealth.org.uk/a-to-z/s/smoking-and-mental-health
Michal, M., Wiltink, J., Reiner, I., Kirschner, Y., Wild, P. S., Schulz, A., . . . Beutel, M. E.
(2013). Association of mental distress with smoking status in the community: Results
from the Gutenberg Health Study. Journal of Affective Disorders, 146(3), 355-360.
doi:10.1016/j.jad.2012.09.019
National Institute of Mental Health. (2019). Major Depression. Retrieved from
https://www.nimh.nih.gov/health/statistics/major-depression.shtml
Newman, M., Sime, A., & Corcoran-Perry, S. (1991). The Focus of the Discipline of Nursing
Advanced Nursing Science, 14(1), 1-6.
Organization, W. H. (2019). Tobacco. Retrieved from https://www.who.int/news-room/factsheets/detail/tobacco
Patient-Centered Primary Care Collaborative. (2019). Instructional Manual: Instructions for
Patient Health Questionnaire (PHQ) and GAD-7 Measures. Retrieved from
https://www.pcpcc.org/sites/default/files/resources/instructions.pdf
Polifroni, C. E., & Welch, M. (1999). Nursing and philosophy of science: Connections and
disconnection. In C.E. Polifroni & M. Welch (Eds.), Perspectives on philosophy of
science in nursing: An historical and contemporary anthology Philadelphia, PA:
Lippincott
Polit, D. F., & Beck, C. T. (2017). Nursing research: Generating and assessng evidence for
nursing practice (10 ed.). Philadelphia: J.B. Lippincott Company

86
Prochaska, Das, & Young-Wolff. (2017). Smoking, Mental Illness, and Public Health. Annu Rev
Public Health, 38, 165-185. doi:10.1146/annurev-publhealth-031816-044618
Prochaska, & DiClemente. (1982). Transtheoretical therapy: Toward a more integrative model of
change. Psychotherapy: Theory, Research & Practice, 19(3), 276-288.
doi:10.1037/h0088437
Prochaska, & DiClemente. (1983). Stages and processes of self-change of smoking: Toward an
integrative model of change. Journal of Consulting and Clinical Psychology, 51(3), 390395. doi:10.1037//0022-006X.51.3.390
Prochaska, & Velicer. (1997). The Transtheoretical Model of Health Behavior Change American
Journal of Health Promotion 12(1), 38-48.
Prochaska, Velicer, DiClemente, & Fava. (1988). Measuring processes of change: Applications
to the cessation of smoking. Journal of Consulting and Clinical Psychology, 56(4), 520528. doi:10.1037//0022-006X.56.4.520
Richardson, S., McNeill, A., & Brose, L. S. (2019). Smoking and quitting behaviours by mental
health conditions in Great Britain (1993-2014). Addictive behaviors., 90, 14-19.
Shi, Y. (2014). Smoking cessation among people seeking mental health treatment. Psychiatric
services (Washington, D.C.), 65(7), 957-960. doi:10.1176/appi.ps.201300444
Smoke Free. (2019a). Health Effects. Retrieved from https://smokefree.gov/quit-smoking/whyyou-should-quit/health-effects
Smoke Free. (2019b). Managing Withdrawal Retrieved from https://smokefree.gov/challengeswhen-quitting/withdrawal/managing-withdrawal
Steinberg, M. L., Williams, J. M., & Li, Y. (2015). Poor mental health and reduced decline in
smoking prevalence. American journal of preventive medicine, 49(3), 362-369.
doi:10.1016/j.amepre.2015.01.016
Taylor, G., McNeill, A., & Aveyard, P. (2015). Does deterioration in mental health after
smoking cessation predict relapse to smoking? BMC Public Health, 15, 1150.
doi:10.1186/s12889-015-2473-z
Toljamo, T., Kaukonen, M., Nieminen, P., & Kinnula, V. L. (2010). Early detection of COPD
combined with individualized counselling for smoking cessation: A two-year prospective
study. Scandinavian Journal of Primary Health Care, 28(1), 41-46.
doi:10.3109/02813431003630105
United Health Foundation. (2019). Smoking in West Virginia. Retrieved from
https://www.americashealthrankings.org/explore/annual/measure/Smoking/state/WV
United Health Foundation. (2021). Retrieved from
https://www.americashealthrankings.org/explore/annual/measure/Depression_a/state/WV
United States Census Bureau. (2019). Quick Facts West Virginia Retrieved from
https://www.census.gov/quickfacts/fact/table/WV/INC910219#INC910219
Velicer, W. F., DiClemente, C. C., Prochaska, J. O., & Brandenburg, N. (1985). Decisional
balance measure for assessing and predicting smoking status. Journal of Personality and
Social Psychology, 48(5), 1279-1289. doi:10.1037//0022-3514.48.5.1279
West Virginia Department of Health and Human Resources. (2021). Statistics about the
Population of West Virginia Retrieved from
https://dhhr.wv.gov/hpcd/data_reports/Pages/Fast-Facts.aspx
Woody, D., DeCristofaro, C., & Carlton, B. G. (2008). Smoking cessation readiness: Are your
patients ready to quit? Journal of the American Academy of Nurse Practitioners, 20(8),
407-414. doi:10.1111/j.1745-7599.2008.00344.x

87
World Health Organization. (2019). Tobacco. Retrieved from https://www.who.int/newsroom/fact-sheets/detail/tobacco
Yohannes, A. M., Hann, M., & Sibbald, B. (2011). The management of depressive symptoms in
patients with COPD: A postal survey of general practitioners. Primary Health Care
Research and Development, 12(3), 237-244. doi:10.1017/S1463423611000041

